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ABSTRACT
Interoceptive exposure (IE) is a treatment entailing induction of feared physiological
sensations that has emerged as the most efficacious component of cognitive behavioral
treatments for panic disorder. However, small-to-moderate effect sizes, wide variability in
response rates, and dropout rates indicate that panic disorder treatments may benefit from
modifications to improve upon retention, response rates, and symptom reduction. Patient
motivation and lack of engagement have been identified as factors to intervene upon. One
specific direction that has gained increasing empirical interest is the inclusion of values
identification; however, research has not yet examined the influence of values on motivation to
engage in IE. The current study was conducted to examine the effect of emphasizing values in
the treatment rationale on treatment selection, willingness to begin treatment utilizing IE,
anticipated adherence to an IE treatment, credibility and expectancy, and acceptability of an IE
intervention. An analogue sample of adults with high anxiety sensitivity were recruited online.
Participants (N = 146) viewed a video containing psychoeducation about the fear of anxiety and
were randomized to receive either the standard IE treatment rationale or values IE treatment
rationale video. In addition, participants responded to self-report questionnaires evaluating
psychological symptoms and information in the videos. The values and standard rationales
yielded similar effects on selection of an IE provider, willingness to begin IE treatment,
anticipated adherence to IE, treatment expectancy and acceptability. However, participants who
received the values rationale reported greater treatment credibility than those who received the
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standard rationale. Overall, the findings from the current study provide insights into treatment
rationales for IE and highlight directions for future investigation.
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I. INTRODUCTION
Panic attacks are characterized by a sudden rush of extreme discomfort that peaks within
minutes, involving physiological and cognitive symptoms such as chest pain or discomfort,
increased heart rate, shortness of breath, dizziness, and fear of dying or losing control (American
Psychiatric Association [APA], 2013). Between 7-28% of the general population will suffer a
panic attack at one point during their lifetime (de Jonge et al., 2016; Eaton et al., 1994; Kessler et
al., 2005). Panic attacks may occur in the absence of a mental disorder or may be linked to a
mental disorder; however, they are the signature feature of panic disorder. Panic disorder is
diagnosed when panic attacks are recurrent and unexpected, and followed by persistent concern
and/or changes in behavior due to the potential of subsequent panic attacks (APA, 2013).
Approximately 4.7% of U.S. adults will receive a panic disorder diagnosis at some point in their
lifetime and 2.7-2.8% of the population are affected each year (de Jonge et al., 2016; Kessler et
al., 2006). Panic disorder is associated with numerous costs, including social impairment
(Klerman et al., 1991; Markowitz et al., 1989), unemployment, absence from work or school,
and occupational impairment (Rollman et al., 2005), chronic medical conditions, and physical
disability (Schmidt & Telch, 1997). Further, panic disorder is often comorbid with other
psychopathology, including major depression (de Jonge et al., 2016; Kessler et al., 1998), bipolar
disorder (de Jonge et al., 2016; Goodwin & Hoven, 2002), and other anxiety disorders (de Jonge
et al., 2016; Goisman et al., 1995), as well as increased risk for suicide (Goodwin & Roy-Byrne,
2006; Kanwar et al., 2013; Sareen et al., 2005).
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Panic disorder is associated with considerable economic burden, as patients with panic
disorder utilize the health care system at substantially high rates, even higher rates than patients
with any other psychiatric diagnoses and without psychiatric diagnosis (Barsky et al., 1999;
Deacon et al., 2008; Katon, 1996, 2006; Klerman et al., 1991; Lynch & Galbraith, 2003; Zane et
al., 2003). Because the physiological symptoms associated with anxiety (e.g., chest pain,
dyspnea) mimic a variety of medical conditions (e.g., heart attack), many individuals suffering
from undiagnosed panic disorder first present to medical settings and continue presenting to
medical settings if panic disorder remains undiagnosed (Katerndahl & Realini, 1995). For
instance, 20% of all emergency room visits are accounted for by patients with panic disorder
(Swinson et al., 1992) and half of all primary care visits in the U.S. are initiated due to
physiological symptoms associated with panic disorder (i.e., heart palpitations, dizziness; Katon,
1996). A study by Marciniak and colleagues (2005) found that individuals with panic disorder
incur an average of $8,078 in total medical costs, which is substantially higher than the $6,475
incurred by individuals diagnosed with any anxiety disorder. Thus, the significant costs
associated with panic disorder have highlighted the need for greater understanding of the
development, maintenance, and treatment of panic disorder.
Cognitive behavioral models of panic disorder (Barlow, 1988, 2002; Clark, 1986)
maintain that recurrent, unexpected panic attacks result from the fear of anxiety-related
physiological sensations (e.g., fear of increased heart rate) and catastrophic misinterpretations
regarding the danger of those sensations (e.g., misinterpreting increased heart rate as an
oncoming heart attack). This fear and beliefs about physiological sensations as dangerous is
referred to as anxiety sensitivity (AS). Both classical and operant conditioning processes are
involved in the development of panic disorder. Specifically, panic disorder is proposed to
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develop when the experience of a panic attack causes anxiety and panic to become classically
conditioned (i.e., pairing of a neutral stimulus with an unconditioned stimulus) to interoceptive
cues (i.e., physiological sensations; Bouton et al., 2001). The likelihood of subsequent avoidance
behaviors (e.g., refraining from going places where one has panicked) and safety behaviors (e.g.,
carrying pill bottles), which provide relief in the short-term, increase via operant conditioning
(i.e., pairing of a behavior with a consequence to increase [reinforce] or decrease [punish] the
likelihood of a behavior). Thus, panic disorder is maintained via negative reinforcement.
Together, these learned responses and AS result in hypervigilance to physiological symptoms
(McNally, 2002), and even mild physiological arousal is interpreted as a warning sign of a panic
attack. Unfortunately, the negatively reinforced avoidance behaviors and safety behaviors
prevent the opportunity for extinction of the conditioned response; thereby, strengthening the
conditioned association between panic and physiological arousal. That is, efforts to avoid said
physiological sensations in an attempt to prevent feared outcomes (e.g., a heart attack) prevents
opportunity for those incorrect beliefs to be disproven (Clark, 1999).
AS is more thoroughly defined as the fear of anxiety-related physical arousal due to
dysfunctional beliefs about their consequences as physically, socially, or cognitively harmful
(Reiss & McNally, 1985). Extensive research has shown that AS is a critical component in the
development, maintenance, and treatment of panic disorder (Baillie & Rapee, 2005; McNally,
2002; Reiss, 1991). For instance, elevated levels of AS are observed in individuals diagnosed
with panic disorder (Deacon & Abramowitz, 2006; Taylor et al., 1992), and longitudinal studies
demonstrate that AS is associated with increased risk for panic attacks (Asmundson & Norton,
1993; Cox et al., 1991). Further, AS fluctuates alongside panic symptoms as evidenced by
correlational and treatment studies (McNally & Lorenz, 1987; Otto et al., 1999; Penava et al.,
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1998; Smits et al., 2004). However, AS is not specific only to panic, but is observed across many
disorders and difficulties including other anxiety disorders (Taylor et al., 1992), and mood
disorders (Cox et al., 2001; Otto et al., 1995; Simon et al., 2005), which has provided support for
AS as a transdiagnostic process.
In accordance with the theoretical models, cognitive behavioral therapy (CBT; Arch &
Craske, 2008) targets panic symptoms via the correction of catastrophic beliefs through exposure
to feared physiological sensations and facilitation of learning that the previously feared
physiological sensations are not dangerous. Panic Control Treatment (PCT; Barlow, Cohen, et
al., 1984; Barlow et al., 1989), the first CBT for panic disorder protocol introduced in the 1980s,
has emerged as one of the most well-studied CBT for panic disorder packages. The initial PCT
protocol prescribed 11-12 60-minute weekly sessions, which focused on psychoeducation about
anxiety and panic, cognitive restructuring of catastrophic and distorted thoughts, breathing
retraining and muscle relaxation, and interoceptive exposure (IE) to feared physiological
sensations (e.g., dizziness, shortness of breath). However, treatment programs for panic disorder
have been considerably refined over the past three decades. For instance, the inclusion of
breathing retraining has received considerable scrutiny. Although breathing retraining provided
mild symptom relief for patients with panic disorder (Clark et al., 1985), its potential
mechanisms of action via distraction and added sense of control lead researchers to question its
theoretical compatibility and added benefits beyond other treatment components (Barlow, 2002).
Results from a dismantling study by Schmidt and colleagues (2000) concluded no additional
benefit of breathing retraining, and consequently, breathing retraining was no longer included as
an essential component (White & Barlow, 2002).
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Other modifications have been made to PCT, such as the addition of in vivo exposure to
feared situations (Craske & Barlow, 1994), including significant others in treatment (Barlow et
al., 1984; Cerny et al., 1987), and adding relapse prevention strategies (Hofmann & Barlow,
1996; Öst, 1989). Additionally, PCT is delivered in abbreviated formats (Côté et al., 1994;
Craske et al., 1995), self-help formats (Gould & Clum, 1995; Hecker et al., 1996), and computerdelivered formats (Newman et al., 1997). As a result of extensive work, current PCT and CBT
for panic disorder packages involve the refined and validated components of psychoeducation,
cognitive restructuring, in vivo exposure to feared situations (e.g., unfamiliar areas, large
crowds), and IE. Nevertheless, research continues to identify ways to refine and individualize
treatment to improve efficacy and reduce costs.
CBT remains the most efficacious psychological treatment for panic disorder (Barlow et
al., 2000a; Hofmann & Smits, 2008; Öst et al., 2004; Penava et al., 1998), as well as anxiety
disorders broadly (Hofmann & Smits, 2008). Substantial reductions in symptoms of panic
disorder are typically observed after delivery of between 12 and 15 sessions (Addis et al., 2004;
Barlow et al., 2000b; Otto & Deckersbach, 1998); yet, some evidence supports the efficacy of
five sessions (Otto et al., 2012) and 2-day intensive treatments (Deacon, 2007; Deacon &
Abramowitz, 2006). Additionally, group CBT for panic disorder is as effective as CBT for panic
disorder delivered via individual treatment (Lidren et al., 1994; Néron et al., 1995). In the first
meta-analysis examining the efficacy of CBT for panic disorder and pharmacotherapy, Mitte
(2005) utilized results from 124 studies and CBT was found to be the superior treatment for
reducing anxiety compared to no-treatment and a placebo control. Depending on the type of
analysis, CBT was as effective or more effective than pharmacotherapy, but there was no
difference between CBT alone and a CBT pharmacotherapy combination (Mitte, 2005). In an
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effort to further examine the specificity of treatment effects, Siev and Chambless (2007)
examined results of five studies comparing CBT to relaxation training for panic disorder. Rates
of clinically significant change (i.e., reduction of scores on panic symptom indices to what is
typical of the “normal” population) were 72% and 50%, respectively, and it was concluded that
CBT was the superior treatment for panic disorder. Lastly, in the most up-to-date analysis of the
efficacy of CBT, Carpenter and colleagues (2018) examined 41 studies comparing CBT to
placebo conditions. CBT for panic disorder was associated with small-to-moderate effect sizes,
highlighting its superiority compared to placebo treatments; yet, also highlights the potential for
further improvement (Carpenter et al., 2018).
Research has demonstrated that IE is the most efficacious component of CBT for panic
disorder (Barlow, 2002; Chambless & Peterman, 2004; Craske & Barlow, 2000; Craske et al.,
1997; Klosko et al., 1990; Penava et al., 1998; Pompoli et al., 2018) and, as expected, an
efficacious intervention for decreasing AS (Boswell et al., 2013). In IE, individuals are exposed
to feared physiological sensations (e.g., dizziness, shortness of breath, pounding heart) by
engaging in tasks that are known to produce the feared physiological sensations (Antony et al.,
2006; Schmidt & Trakowski, 2004). Symptom induction exercises used in IE modules of CBT
for panic disorder include head shaking, head lifting, step-ups, breath holding, muscle tension,
spinning, hyperventilation, breathing through a narrow straw, and mirror staring. Most notably,
examinations of the effects of symptoms induction tasks revealed hyperventilation, breathing
through a straw, spinning, and running in place as producing physiological sensations of the
highest intensity (Antony et al., 2006; Schmidt & Trakowski, 2004). Similarly, hyperventilation,
breathing through a straw, spinning, and using a tongue depressor were identified as producing
the most fear and being the most similar to panic (Antony et al., 2006; Schmidt & Trakowski,
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2004). By repeatedly engaging in these tasks, individuals experience habituation to the feared
physiological sensations and corrective learning (Craske & Barlow, 2000; Schmidt et al., 2000).
That is, repeated induction of the feared physiological sensations (e.g., pounding heart) without
the feared consequences (e.g., heart attack) results in extinction of the fear response. Corrective
learning then allows for the feared physiological sensations to possess two different meanings,
(1) the excitatory meaning (e.g., pounding heart associated with fear of having a heart attack) and
(2) an inhibitory meaning (e.g., pounding heart not associated with having a heart attack).
Research has also established efficacy for IE as a standalone treatment for panic disorder
(Beck et al., 1997; Broocks et al., 1998; Griez & van den Hout, 1986). For example. Beck and
colleagues (1997) presented seventeen panic disorder patients with 6 sessions of IE using 35%
CO2 inhalations. Significant reductions in worry about panic and interference from panic were
observed across patients at posttreatment and follow-up, with only 35% meeting diagnostic
criteria at posttreatment and 18% meeting diagnostic criteria at follow-up. Additionally, IE is not
only effective at treating panic disorder but has demonstrated utility in the treatment of a variety
of disorders and conditions with associated AS, including anxiety disorders (Boswell et al., 2013;
Hunter & Antony, 2009; Plotkin, 2002; Telch et al., 2004; Walker & Furer, 2008), posttraumatic
stress disorder (PTSD; Otto et al., 2003; Wald & Taylor, 2005, 2007; Wald et al., 2010), eating
disorders (Boswell et al., 2019); certain health conditions (e.g., irritable bowel syndrome; Craske
et al., 2011; Flack et al., 2018; Shipherd, 2006; Watt et al., 2006; Zucker et al., 2017); and some
forms of substance use disorder (Zvolensky et al., 2003, 2008). Thus, efforts have been geared
toward refining IE given its wide utility.
Although CBT including IE has been identified as the most efficacious evidence-based
intervention for anxiety disorders (Hofmann & Smits, 2008; Norton & Price, 2007; Tolin, 2010),
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there remains considerable room for improvement. For example, in the most recent meta-analysis
of CBT for anxiety disorders, Carpenter and colleagues (2018) found a small-to-moderate effect
size (Hedges’ g) of 0.38 for panic disorder, whereas effect sizes for other anxiety disorders
ranged from 0.41 to 1.13 (i.e., moderate to large effects). Further, among individuals with panic
disorder seeking treatment, a considerable proportion either do not experience clinically
significant responses to treatment or do not maintain gains after treatment (Loerinc et al., 2015).
A recent meta-analysis conducted by Loerinc and colleagues (2015) found that CBT for panic
disorder response rates (i.e., percentage of individuals in treatment groups that were classified as
responders to treatment) were 53.2% post treatment and 59.3% at follow-up. In addition, there
was considerable variability in response rates, with rates ranging from 10-97% post treatment
and 1-100% at follow up. Finally, a meta-analysis by Haby and colleagues (2006) estimated the
average dropout rate among individuals receiving CBT for panic disorder was 19% and ranged
from 0-54%. Taken together, these studies illustrate the need to modify panic disorder treatments
to improve upon retention, response rates, and symptom reduction.
In an attempt to identify barriers for successful treatment with CBT for panic disorder in
clinical practice to researchers, a collaborative effort was formed between the Society of Clinical
Psychology (Division 12 of the APA) and the Division of Psychotherapy (Division 29 of the
APA). Practicing clinicians (N = 338) who use CBT for panic disorder were recruited to
participate in a survey via advertisements on listservs and newsletters of professional
psychological organizations (e.g., Association for Behavioral and Cognitive Therapies). A
variety of patient factors as barriers to successful treatment were endorsed, including the
chronicity and severity of panic disorder symptoms, patient social systems, the therapeutic
relationship, difficulty implementing treatment, and patient motivation. Interestingly, patient
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motivation was commonly identified as a significant problem that interfered with treatment
(Wolf & Goldfried, 2014). Specifically, results indicated that 60% reported premature
termination, 60% reported minimal motivation at treatment onset, and 31% reported decreased
motivation following some reduction in symptoms. Similarly, Sanderson and Bruce (2007) found
patient lack of engagement was the most frequently endorsed factor associated with suboptimal
progress in treating panic disorder and endorsed by 60% of expert clinicians. Thus, both Wolf
and Goldfried (2014) and Sanderson and Bruce (2007) suggest that clinicians consider the use of
motivational techniques, such as those in Motivational Interviewing (MI; Miller & Rollnick,
2002) as an adjunct to CBT for panic disorder to address lack of engagement.
Numerous therapeutic techniques have been used to facilitate patient motivation in
treatment; however, one specific direction that has gained increasing empirical interest is the
inclusion of values identification (Hayes et al., 2012). Values, a core component of MI, are
broadly defined as personal choices about what an individual finds to be important in life, which
can motivate, guide, and direct purposeful behavior, and lead to intrinsic satisfaction (Dahl et al.,
2009). The processes underlying the influence of values on behavior have been thoroughly
investigated and documented in the behavior analytic literature.
Values serve to alter the functions of stimuli or events through establishing operations
(Leigland, 2005; Michael, 1982), defined as events that temporarily alter the reinforcing qualities
of other events (Michael, 1982, 1993). Although notably more complex than events involved in
establishing operations, human language can be used to alter the reinforcing qualities of events in
a similar way via augmental verbal contingencies (Zettle & Hayes, 1982). For example, a mother
may tell her child that he will receive a gold sticker each day that he behaves well at school, and
that these stickers can be exchanged for extra play time. If this child finds extra play time
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appetitive, this will serve to augment the stickers, such that merely receiving a gold sticker will
reinforce his behaving well at school. Because these processes allow for influence to be exerted
over behavior without individuals ever having any history of contact with a particular given
contingency, behavior can fall under control of consequences that are highly abstract (Törneke,
2010). In the complex context of human values, these verbal establishing operations are referred
to as motivative augmental rules. For example, if a man values being a caring husband, this can
augment events such as his partner talking about her day and her eating dinner that he prepared
such that they motivate and reinforce behaviors consistent with being a caring husband. Stated
simply, clarifying one’s values can motivate behavior that is consistent with said values (Dahl et
al., 2009).
Given this understanding of how values can alter the appetitive and reinforcing qualities
of other events and this guide behavior that is complex and abstract, values have been
incorporated as a motivational component in empirically supported behavioral techniques and
treatments. For instance, values have been incorporated in motivational interviewing.
Motivational interviewing is a transtheoretical therapy approach that emphasizes resolving
ambivalence about behavior change and strengthening motivation for change through the use of
values (Miller & Rollnick, 2002). In motivational interviewing, patients are interviewed about
their values and how their values connect to treatment goals. Discrepancies between valued
behavior and current behavior are discussed to resolve ambivalence about change and motivate
commitment to change. Evidence supports the efficacy of motivational interviewing as a
standalone treatment for substance use disorders (Burke et al., 2002, 2003; Dunn et al., 2001).
Moreover, evidence supports the efficacy of motivational interviewing as a treatment adjunct to
motivate engagement in other psychological interventions, including CBT for mood and anxiety
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disorders (Randall & McNeil, 2017; Romano & Peters, 2015). In a recent meta-analysis, Marker
and Norton (2018) concluded that treatment outcomes, including anxiety symptom reduction, are
improved when motivational interviewing is included as an adjunct to CBT for anxiety disorders
compared to CBT for anxiety disorders alone. Additionally, the use of motivational interviewing
is supported by indices of treatment motivation such as treatment attendance (Saunders et al.,
1995), homework adherence (Westra & Dozois, 2006), and medication compliance (Interian et
al., 2010).
Brief Behavioral Activation Treatment for Depression (BATD) packages (e.g., Lejuez et
al., 2001, 2011) have also emphasized patient values in treatment, specifically in scheduling
behavioral activities. In BATD, the clinician assists the patient in identifying values and
developing a schedule of activities and goals that are consistent with each of their identified
values (Lejuez et al., 2001). Though no studies to date comparing effectiveness of behavioral
activation treatments without values to BATD variants are known to the author, evidence
supports the efficacy of BATD at improving depressive symptoms (Daughters et al., 2008;
Gawrysiak et al., 2009; Hopko et al., 2003, 2005; MacPherson et al., 2010; Pagoto et al., 2008)
and comorbid anxiety and depressive symptoms (Hopko et al., 2004).
Additionally, values have been incorporated in Acceptance and Commitment Therapy
(ACT; Hayes et al., 1999). ACT is an empirically driven expansion of traditional behavior
therapy that deems identification of values and promoting valued behavior as the primary
purpose of treatment. The emphasis on values in ACT is specifically stated to be in support of
“providing a context in which a client may be more willing to experience difficult thoughts and
feelings as she moves in valued directions” (Dahl et al., 2009, p. 10). In ACT, clinicians assist
patients in identifying values, setting values-based goals, and monitoring progress toward said
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goals (Hayes et al., 2012). Evidence supports the efficacy of ACT for an array of problems,
ranging from chronic pain (Hughes et al., 2017) and smoking cessation (Gifford, Kohlenberg,
Hayes, Antonuccio, Piasecki, et al., 2004), to depression and anxiety disorders (A-tjak et al.,
2015; Twohig & Levin, 2017), mixed anxiety disorders (Arch et al., 2012), and panic disorder
(Eifert et al., 2009). Additionally, evidence supports the efficacy of ACT in motivating treatment
adherence, measured specifically by treatment attendance (Luoma et al., 2012) and attrition
(White et al., 2011).
Evidence from randomized controlled trials (RCTs) have generally supported the
inclusion of packages containing values components in facilitating exposure therapy. Westra and
Dozois (2006) compared a three-session motivational interviewing pre-treatment adjunct to
group CBT for anxiety disorders to a no pre-treatment group for 55 patients with a principal
anxiety diagnosis (45% diagnosed with panic disorder). The motivational interviewing pretreatment group not only evidenced greater homework compliance but an increase in treatment
responders compared to the no pre-treatment group (Westra & Dozois, 2006). Evidence has also
favored the inclusion of packages containing values components among patients who have
previously refused exposure therapy. Maltby and Tolin (2005) examined agreement to begin
exposure therapy among 12 patients with obsessive-compulsive disorder who had recently
refused exposure therapy. Patients were randomized into either a four-session MI-based
readiness to exposure therapy group or a waitlist control group. Following a four-week period,
86% of patients who received the MI-based adjunct elected to begin exposure therapy, whereas
only 20% of the control condition elected to begin exposure therapy.
Further, there is preliminary evidence supporting the inclusion of packages containing
values components in exposure therapy in CBT for panic disorder. In an unpublished
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dissertation, Karekla (2004) compared an ACT-enhanced PCT and PCT alone for 22 patients
diagnosed with panic disorder. No differences on treatment outcome variables or attrition totals
were observed between the two groups; however, differences in the pattern of treatment attrition
between conditions emerged. In the PCT condition, the majority of patients dropped out of
treatment following the introduction of the exposure component. In the ACT-enhanced PCT
condition, there were no dropouts at the introduction of exposure, rather patient dropouts were
evenly distributed over the course of treatment. Thus, Karekla (2004) concluded that an
acceptance- and values-based rationale may increase motivation to engage in the necessary
exposure exercises.
To date, there are no randomized controlled dismantling studies examining the inclusion
of a values component in exposure therapy; however, laboratory research has aided in
experimental analysis of the influence of values on engagement in exposure tasks. For instance,
Páez-Blarrina and colleagues (2008), examined the influence of an ACT-values rationale, a
control values rationale, and a no values rationale on performance during a pain tolerance task.
The ACT-values rationale involved interviewing participants about their values and integrating
the pain to be experienced as part of a valued direction, whereas the control values rationale
established pain as being incompatible with valued actions. Participants then received electric
shocks of increasing pain during a computerized task with the option to discontinue until the
maximum of 15 shocks. Results revealed that 70% of participants in the ACT-values condition
tolerated the maximum of 15 shocks, even after reporting “very much pain,” whereas only 10%
and 20% of participants in the control values and untrained conditions reached the maximum
number of shocks. Thus, Páez-Blarrina and colleagues’ (2008) findings support the motivational
context of values on exposure to pain tolerance. In a similar study that examined the influence of
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values on behavior in an exposure task, Branstetter-Rost and colleagues (2009) examined the
effects of an acceptance intervention with and without values on pain tolerance during a coldpressor task. The values component involved a discussion of the participant’s values and
tolerance of physical pain in service of their most deeply held value. Results revealed that
participants in the acceptance plus values condition demonstrated greater pain tolerance,
measured by length of time in the cold water, than the acceptance alone and control conditions.
Thus, Branstetter and colleagues’ (2009) findings again support the role of values in motivating
behavior and toleration in the context of physical pain.
Experimental analogue research has further explicated the influence of values on
performance during exposure tasks. Bluett (2014) experimentally manipulated the rationale for
exposure exercises for 81 socially anxious adults. In this two-session exposure-based
intervention participants were randomized to receive either a fear reduction rationale, a
psychological flexibility rationale, a values rationale, or no rationale (control condition) for
engaging in the exposure exercises. The values rationale involved interviewing participants about
their values and instructing participants to focus on their values while engaging in the exposure
exercises. Participants were asked to engage in a 10-minute exposure exercise (e.g., public
speech) at session one, between session exposure tasks, and then another 10-minute exposure
exercise (e.g., public speech once again) at session two. Though results indicated no group
differences in homework compliance (e.g., amount of between-session exposure tasks
completed), group differences emerged with regard to time of engagement during the in-session
exposure exercises. At session one, participants who received an active intervention (e.g., fear
reduction rationale, psychological flexibility rationale, or values rationale) gave longer speeches
(e.g., spoke for the full suggested 10 minutes) than participants in the control condition. In the
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second session, though speech time did not differ between active conditions, more participants in
the values condition spoke for the entire time (e.g., 10 minutes) compared to those in the fear
reduction condition. Thus, Bluett (2014) concluded that incorporating values may be an effective
approach to fostering engagement in exposure-based interventions.
Taken together, existing evidence suggests that incorporation of values may motivate
engagement in IE (Bluett, 2014; Branstetter-Rost et al., 2009; Karekla, 2004; Maltby & Tolin,
2005; Páez-Blarrina et al., 2008; Westra & Dozois, 2006). However, prior research has included
additional components when examining the influence of values, such as those involved in
motivational interviewing (Miller & Rollnick, 2002), BATD (Lejuez, et al., 2011; Lejuez et al.,
2001), and ACT (Hayes et al., 1999), that prevent the independent examination of values on
motivation to engage in exposure exercises. Further, there is no research known to date by the
author that examines the influence of values on motivation in IE, in particular. Therefore,
research examining the effect of a values component in isolation on motivation to begin and
acceptability of IE exercises is needed. The results of this study have the potential to further
improve treatment efficacy reducing costs associated with panic disorder and the many other
conditions treated by IE.
Current Study
The purpose of the current study was to examine the effect of emphasizing values in the
treatment rationale on treatment selection, willingness to begin treatment utilizing IE, anticipated
adherence to an IE treatment, credibility and expectancy, and acceptability of an IE intervention.
This study utilized a clinical analogue sample of adults with elevated AS, a risk factor for panic
attacks and the development and maintenance of panic disorder (Baillie & Rapee, 2005;
McNally, 2002; Reiss, 1991). Participants were randomly assigned to receive one of two
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rationales: (1) a values rationale, or (2) a standard rationale. The primary dependent variables for
the current study were treatment selection, willingness to begin treatment utilizing IE, anticipated
adherence to an IE treatment, credibility and expectancy, and acceptability of IE. The primary
independent variable was emphasis of IE rationale: (a) values rationale, or (b) standard rationale.
The following hypotheses were examined:
1. Participants in the values condition will be more likely to select IE when asked to select a
treatment provider, as assessed by the Treatment Selection Survey, than those in the
standard condition.
2. Participants in the values condition will be more willing to begin IE treatment by booking
the appointment offered or requesting a different appointment time when offered an
appointment to receive IE treatment, as assessed by the IE Appointment Survey, than
those in the standard condition.
3. Participants in the values condition will report greater anticipated adherence to IE, as
assessed by the Treatment Adherence and Acceptability Scale, than those in the standard
condition.
4. There will be no difference in treatment credibility and expectancy, as assessed by the
Credibility/Expectancy Questionnaire, between the values condition and standard
condition.
5. Participants in the values condition will report greater acceptability of treatment, as
assessed by the Treatment Acceptability Questionnaire, than those in the standard
condition.
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II. METHODS
Participants
An a priori power analysis was conducted using G*Power 3 (Faul et al., 2007) to
determine the sample size necessary to conduct an independent samples t-test. Results indicated
that a minimum sample of 126 participants (64 participants per group) would be needed to
detect, with 95 percent confidence, a medium effect size (i.e., Cohen’s d = .5). Thus,
approximately 170 participants (85 participants per group) were recruited for participation via
Amazon’s Mechanical Turk (MTurk) using TurkPrime (Litman et al., 2017). MTurk is an online
crowdsourcing platform through which workers complete online tasks for compensation. MTurk
has been increasingly used as a research platform in behavioral sciences, and evidence supports
the use of MTurk in conducting clinical research (Chandler & Shapiro, 2016; Shapiro et al.,
2013) and to recruit anxious samples (Arch et al., 2015; Arditte et al., 2016; Shapiro et al., 2013).
MTurk workers in the United States who had completed a minimum of 100 tasks with an
approval rating of at least 95% (N = 387) were eligible for participation in the study. Criteria
regarding number of tasks completed and approval rating were selected to increase the
probability of high-quality data (Peer et al., 2014). Of those (n = 256) who screened positive for
clinical levels of anxiety sensitivity, 27 individuals declined to participate in the full study.
Participants were excluded for: a total score below the anxiety sensitivity clinical cutoff (n =
131), premature withdrawal from the study (n = 53), failing items of inattention and careless
responding (n = 5; e.g., “If you are paying attention, please select ‘Chair’ below”), and entering
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nonsense syllables or irrelevant responses into text boxes (n = 24). See Figure 1 for a participant
flow diagram.
The final sample (N = 146) consisted of slightly more females (54.1%) than males
(43.2%). Participants were predominantly White (73.3%), ranging in age from 18 to 65 with an
average age of 32.36 years (SD = 9.01). See Table 1 for a full description of sociodemographic
characteristics of the sample.
Assessed for eligibility
(N = 387)

Randomized into condition
(n = 146)

Allocated to Values Condition
(n = 72)

Excluded (n = 241)
• Total score less than 23 on the
ASI-3 (n = 131)
• Declined participation (n = 27)
• Withdrew prematurely (n = 53)
• Careless responding (n = 30)

Allocated to Standard Condition
(n = 74)

Figure 1. Participant flow.
Measures
Anxiety Sensitivity Index – 3 (ASI-3). The ASI-3 (Taylor et al., 2007) is an 18-item
self-report measure of the fear of physiological arousal-related sensations. The ASI-3 consists of
a three-factor structure, with six items assessing physical concerns (e.g., “When I feel pain in my
chest, I worry that I am going to have a heart attack”), six items assessing social concerns (e.g.,
“I worry that other people will notice my anxiety”), and six items assessing cognitive concerns
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(e.g., “When my thoughts seem to speed up, I worry that I might be going crazy”). Participants
were asked to evaluate each statement from “very little” to “very much” on a five-point Likert
scale. Scores on the ASI-3 can range from 0 to 72, with higher scores reflecting greater fear of
arousal-related symptoms. The total score was used in the current study to screen participants
and as a general measure of AS. Participants who scored at or above a total of 23 on the ASI-3,
indicative of high AS (see Allan et al., 2014), were invited to participate in the study. The ASI-3
total and subscales demonstrate excellent convergent, discriminant, and criterion-related validity
(Taylor et al., 2007). The ASI-3 demonstrated good reliability (α = .83) in the current sample.
Demographic and Medical Questionnaire. Participants were given a short measure that
included items such as age, gender, ethnicity, as well as current and past medical conditions,
current and past treatment for an anxiety disorder, and current psychiatric medications.
Fear of COVID-19 Scale (FCV-19S). The FCV-19S (Ahorsu et al., 2020) is a recently
developed seven item self-report measure of fear of the COVID-19 pandemic. Participants were
presented with statements such as “I am afraid of losing my life because of Coronavirus-19” and
asked to evaluate each item from “strongly disagree” to “strongly agree” on a five-point Likert
scale. Scores on the FCV-19S can range from 7 to 35, with higher scores reflecting higher levels
of fear. The FCV-19S demonstrates good internal consistency, convergent, divergent and
criterion-related validity (Ahorsu et al., 2020; Winter, et al., 2020). The FCV-19S demonstrated
good reliability (α = .89) in the current sample.
Albany Panic and Phobia Questionnaire (APPQ). The APPQ (Rapee et al., 1995) is a
27-item self-report measure of the fear of activities often avoided by individuals with
agoraphobia and social phobia, and activities that typically produce physical sensations. The
APPQ consists of a three-factor structure with nine items assessing activities feared by
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individuals with agoraphobia (e.g., “Walking alone in isolated areas”), nine items assessing
activities feared by individuals with social phobia (e.g., “Giving a speech”), and nine items
assessing activities that typically produce interoceptive sensations (e.g., “Running upstairs).
Participants were asked to evaluate each activity item from “no fear” to “extreme fear” on a ninepoint Likert scale. Scores on the APPQ can range from 0 to 216, with higher scores reflecting
higher levels of fear. The APPQ subscales demonstrate good internal consistency, convergent,
divergent, and criterion-related validity (Rapee et al., 1995). In the current sample, good internal
consistency was observed for all three scales (s = .79 - .85).
Willingness to tolerate distress. Willingness to tolerate distress was assessed by
utilizing activities on the APPQ – Agoraphobia subscale and asking participants to respond to the
question, “How willing would you be to do [most feared activity] next week?” Responses range
from 0% (not at all willing) to 100% (extremely willing). Scores for all nine items were averaged
for a total willingness score.
Treatment Options. To assess provider preference and willingness to begin IE
treatment, the Treatment Selection Survey and IE Appointment Survey were administered.
Provider Selection Survey. Selection of an IE provider was assessed by a one-item
survey developed by the author. Participants were instructed to “Select a provider with whom
you would like to follow through with treatment,” for which response options consisted of an IE
provider, other mental health care provider, or no provider. Prior studies support the use of
similar items to assess mental health treatment preference and selection (Dwight-Johnson et al.,
2000; Gardner et al., 2015; Gum et al., 2006; Lang, 2005; Lin et al., 2005; Pearlstein et al., 2006;
Wetherell et al., 2004).
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IE Appointment Survey. Willingness to begin IE treatment was assessed by a one-item
survey developed by the author. Participants were presented with the following information:
“There is an opening for treatment to be provided free of cost on Monday, August 10 at 9:00 AM
CST via telehealth from a therapist at the University of Mississippi Psychological Services
Center. It does not matter where in the United States you are physically located. All that would
be needed is: an hour and a half of your time, an electronic device with video and audio
capability (e.g., laptop, smartphone, tablet), and a stable internet connection. Would you like to
book this appointment for treatment?” Participants were offered an opportunity to decline
treatment, book the appointment for treatment, or request another date and time for treatment.
Treatment Acceptability and Adherence Scale (TAAS). The TAAS (Milosevic et al.,
2015) is a ten-item self-report measure of anticipated adherence to a given treatment. Participants
were provided with items such as “If I participated in this treatment, I would be able to adhere to
its requirements” and indicate agreement ranging from “disagree strongly” to “agree strongly” on
a seven-point Likert scale. Scores on the TAAS can range from 10 to 70 and higher scores reflect
greater treatment acceptability and anticipated ability to adhere to it. The TAAS demonstrates
acceptable to good internal consistency, good convergent and divergent validity (Milosevic et al.,
2015). The TAAS demonstrated good reliability (α = .86) in the current sample.
Credibility/Expectancy Questionnaire (CEQ). The CEQ (Devilly & Borkovec, 2000)
is a six-item self-report measure of treatment expectancy and rationale credibility widely used in
psychotherapy research. The CEQ consists of a two-factor structure. On the credibility subscale,
participants were provided with four questions such as, “At this point, how successfully do you
think this treatment will be in reducing your symptoms?” and responded to them ranging from
“not at all” to “very much” on a nine-point Likert scale. On the expectancy subscale, participants
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were provided with two items assessing the extent of improvement the participant expects as a
result of the treatment from 0% to 100%. Higher scores reflect greater levels of treatment
expectancy and rationale credibility. The CEQ demonstrates high internal consistency and good
test-retest reliability (Devilly & Borkovec, 2000). In the current sample, good internal
consistency was observed for both the credibility ( = .84) and expectancy ( = .88) subscales.
Treatment Acceptability Questionnaire (TAQ). A three-item self-report questionnaire
was administered to participants to assess acceptability of the treatment provided. Participants
rated the treatment’s acceptability, likeability, and aversiveness from “not at all” to “extremely”
on a five-point Likert scale. The TAQ demonstrated good reliability (α = .76) in the current
sample.
Procedure
All procedures were approved by the University of Mississippi’s institutional review
board prior to the start of participant recruitment. Eligible workers were presented with a brief
overview of the purpose of the screener, tasks involved, risks and benefits, and the ASI-3 was
completed by those who consented. Participants were compensated $0.10 for completion of the
ASI-3. Participants meeting cutoff criteria on the ASI-3 (total score ≥ 23) were invited to
participate in the larger questionnaire study. Interested participants were provided with a brief
overview of the purpose of the study, the procedure and tasks involved, the risks and benefits of
participation in the study, confidentiality, a description of compensation, and the participant’s
right to withdraw at any point during the study. Participants were compensated an additional
$3.00 for completion of all study procedures. See Appendix A for a copy of each measure
described above.
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After providing consent, participants were randomly assigned to the experimental (values
rationale) or control condition (standard rationale) via Qualtrics Randomize function.
Participants first completed a series of questionnaires including: Demographic and Medical
Questionnaire, FCV-19S, APPQ, and Willingness to Tolerate Distress items. Then, participants
viewed a two-minute video that provided information about the fear of physiological sensations
(i.e., psychoeducation; See Appendix B for a copy of the script used in the psychoeducation
video). Consistent with Barlow and Craske (2007), the researcher described the fear of
physiological sensations as the product of inaccurate beliefs about the potential for threat and the
diminished belief that one can appropriately tolerate fear and the related physiological
sensations. Next, participants viewed a brief three-minute video either describing the values
rationale or the standard rationale for IE treatment. Steps were taken to increase the likelihood of
engagement with the videos (i.e., participants were prevented from forwarding to the next
portion of the study until the time of the length of the video has elapsed). Last, participants
completed the CEQ, Treatment Acceptability Questionnaire, TAAS, Treatment Selection
Survey, and the IE Appointment Survey. All participants were debriefed about the purpose of the
study upon completion or withdrawal from the study, which included a description of the
rationale of the study along with information about treatments for anxiety, resources, and referral
information participants interested in pursuing treatment for anxiety or panic.
Values rationale. See Appendix B for a copy of the script used in the values rationale
video. The values rationale used for a coping with pain task implemented by Páez-Blarrina and
colleagues (2008) was adapted to integrate examples relevant to distress and discomfort specific
to interoceptive exposure for the current study. In the values rationale condition, an example was
provided of an individual engaging in a task that related to a deeply held value despite severe

23

discomfort (i.e., persisting in chemotherapy treatment for cancer despite aversive side effects).
The participant was prompted to think about why most people undergoing chemotherapy do not
quit. The participant was then prompted to recall an instance when the participant engaged in a
task that involved severe discomfort in order to do something valued. Two more examples of an
individual engaging in a task related to a value despite discomfort were provided (i.e., spending
time studying for a degree, traveling a long distance to see a loved one). Next, IE was described
as an effective procedure designed to help individuals tolerate uncomfortable body sensations so
they can engage in more that they value. The straw breathing task was provided as an example of
a task involved in IE treatment. The experimenter described the straw breathing task (i.e.,
breathing through a cocktail straw for 60 seconds), symptoms elicited during the task (i.e.,
breathlessness, dizziness, increased heart rate), and gave a brief five-second demonstration of the
task. Participants were informed that IE involves repeating exercises enough times and in the
right way such that new learning occurs and conditioning is broken so they can engage in more
that they value. Following this video, participants completed the final questionnaires (i.e., CEQ,
Treatment Acceptability Questionnaire, TAAS, Treatment Selection Survey, and the IE
Appointment Survey).
Standard rationale. See Appendix B for a copy of the script used in the standard
rationale video. The rationale for engaging in IE described by Barlow and Craske (2007) was
adapted for the current study to match the length and examples provided in the values rationale.
Participants randomly assigned to the standard rationale condition were provided with an
example of an individual engaging in a task that elicited severe discomfort before the individual
quit (i.e., experiencing heart pounding, sweating, and difficulty breathing while attempting to run
five miles before stopping). The participant was then prompted to recall and provide an example
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of an instance when the participant engaged in a task that involved severe discomfort, so they
had to quit. Another example of an individual engaging in a task, experiencing severe
discomfort, and quitting was provided (i.e., studying hard, experiencing an unbearable headache,
then stopping). Next, IE was introduced as an effective procedure to help individuals tolerate
uncomfortable body sensations so fear of body sensations can be reduced and they can feel
better. The straw breathing task was demonstrated as an example and participants were informed
that IE involves repeating exercises enough times and in the right way such that new learning
occurs and conditioning is broken so they can experience less discomfort related to anxious body
sensations. Following this video, participants completed the final questionnaires (i.e., CEQ,
Treatment Acceptability Questionnaire, TAAS, Treatment Selection Survey, and the IE
Appointment Survey).
Data Analytic Approach
All statistical analyses for the current study were performed with the SPSS Version 26
statistical package. A significance level of p <.05 was used for all statistical analyses. Scores on
all self-report measures were assessed for normality and examined for skewness and kurtosis.
Descriptive analyses were conducted on all variables for each condition at each assessment.
Prior to testing the hypotheses, a series of independent samples t-tests and chi square
analyses were conducted to evaluate between groups equivalence on demographic and
psychological variables. Results from an independent samples t-test revealed no significant age
differences between groups, t(144) = -0.406, p = .686. A chi-square analysis revealed no
significant gender differences between groups, X2 = (3, N = 146) = 4.687, p = .196. Additionally,
independent samples t-tests revealed no significant differences between groups regarding AS,
t(144) = 0.411, p = .682, fear of activities that typically produce interoceptive sensations, t(144)
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= 0.032, p = .975, or fear of activities typically avoided by individuals with agoraphobia, t(144)
= 1.101, p = .273 or social phobia, t(144) = 0.989, p = .324., or willingness to engage in activities
typically avoided by individuals with agoraphobia, t(144) = -0.097, p = .923. Chi square analyses
revealed no significant differences between groups regarding diagnosis of an anxiety disorder, X2
= (1, N = 146) = 1.338, p = .247, or endorsement of panic attack(s), X2 = (1, N = 146) = 0.948, p
= .330. With regard to COVID-19 distress, an independent samples t-test revealed no differences
between groups, t(144) = 1.639, p = .103. In addition, chi square analyses revealed no
differences between groups in infection of COVID-19, X2 = (1, N = 136) = 2.030, p = .154. In
sum, group equivalence was supported as no significant differences between groups were
observed on the baseline and demographic variables; thus, no control variables were included in
the primary analyses. To test the study hypotheses, a series of t-tests and chi-square analyses
were conducted.
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III. RESULTS
Descriptive Statistics and Sample Characteristics
Means and standard deviations for all measures are presented in Table 2. Normality of
data was assessed, and skewness and kurtosis for each measure were within the acceptable range.
Most participants (69.9%) endorsed a history of at least one panic attack and 56.8%
reported experiencing panic attack(s) in the past year. Of those with a history of at least one
panic attack, the majority (84.3%) reported the panic attack(s) being unexpected or occurring out
of the blue. Half of participants (49.3%) reported a lifetime anxiety disorder diagnosis. About a
third of participants (38.4%) reported currently taking medication for mental health problems.
The majority of patients (69.9%) denied any history of psychological treatment, including
therapy.
The current sample’s mean score of 37.23 (SD = 10.9) on the ASI-3 was similar to other
samples with elevated AS, yet higher than panic disorder samples found by Taylor and
colleagues (2007; M = 32.6, SD = 14.3) and Rifkin and colleagues (2015; M = 29.3, SD = 12.8).
Scores on the ASI-3 physical concerns subscale (vs. social and cognitive concerns) were the
most pronounced in the current sample.
Regarding the APPQ, the current sample’s mean score of 16.11 (SD = 10.93) on the panic
subscale was equivalent to APPQ panic subscale scores for a panic disorder sample with
moderate/severe avoidance (Rapee et et al., 1995; M = 16.3, SD = 13.5). The current sample’s
mean score of 24.52 (SD = 12.72) on the agoraphobia subscale was lower than APPQ
agoraphobia subscale scores for a panic disorder sample with moderate/severe avoidance (M =
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32.3, SD = 13.7); yet, higher than APPQ agoraphobia subscale scores for a panic disorder
sample with mild avoidance (M = 20, SD = 14.4). The current sample’s mean score of 37.73 (SD
= 14.44) on the social phobia subscale was higher than APPQ social phobia subscale scores for a
panic disorder sample with moderate/severe avoidance (M = 20.8, SD = 14.2), and also higher
than APPQ social phobia subscale scores for a social phobia sample (M = 31.5, SD = 13.2;
Rapee et al., 1995).
Regarding fears of COVID-19, the current sample’s mean score of 19.49 (SD = 7.01) on
the FCV-19S was elevated compared to FCV-19S scores among a U.S. college sample (M =
18.1, SD = 7.1; Perz et al., 2020). The current sample’s score was also elevated compared to
FCV-19S scores found in an outpatient psychiatric sample in Taiwaan (M = 18.46, SD unknown;
Chang et al., 2020).
Primary Analyses
Selection of an IE provider. Participants in the values condition were hypothesized to be
more likely to select an IE provider (Hypothesis 1) than those in the standard condition. To test
this hypothesis, chi square analyses were conducted. Results revealed no differences in selection
of an IE provider between groups, X2 = (1, N = 146) = 3.063, p = .080. See Table 3 for chi-square
test results and descriptive statistics for provider selection by condition.
Willingness to begin treatment. Participants in the values condition were hypothesized
to be more willing to book the appointment offered or request a different appointment time when
offered an appointment to receive IE treatment (Hypothesis 2) than those in the standard
condition. To determine differences in bookings of appointment for IE treatment between
groups, chi square analyses were conducted. For analytic purposes, both options “Yes, I would
like to book this appointment” and “No, because this date and time does not work for me, but I
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am interested in selecting another appointment time” were coded as “yes,” whereas options “No,
because I am not interested in treatment” and “No, because I am not interested in online
treatment” were coded as “no.” Results revealed no significant between group differences in
booking of appointment for IE treatment, X2 = (1, N = 146) = 0.417, p = .519. See Table 4 for
chi-square test results and descriptive statistics for appointment booking by condition.
Anticipated adherence to treatment. Participants in the values condition were
hypothesized to report greater anticipated adherence to IE (Hypothesis 3) than those in the
standard condition. To determine differences in anticipated adherence to treatment between
groups, an independent samples t-test was conducted. Results revealed there was no significant
difference in anticipated adherence to treatment between groups, t(144) = -1.677, p = .096.
Treatment credibility and expectancy. It was hypothesized that there would be no
difference in treatment credibility and expectancy (Hypothesis 4) between the values condition
and the standard condition. To determine differences in treatment credibility and expectancy, two
independent samples t-tests were conducted. Results revealed a significant difference in
treatment credibility between groups, t(144) = 2.537, p = .012, such that treatment credibility in
the values condition was higher than that in the standard condition. Results revealed no
significant difference in treatment expectancy between groups, t(144) = 0.430, p = .093.
Treatment acceptability. Participants in the values condition were hypothesized to will
report greater acceptability of treatment (Hypothesis 5) than those in the standard condition. To
determine differences in acceptability of treatment between groups, an independent samples ttest was computed. Results revealed no differences in treatment acceptability between groups,
t(144) = 1.413, p = .160.
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IV. DISCUSSION
The current study is the first known to investigate the effect of emphasizing values in the
treatment rationale for IE on treatment selection, willingness to begin treatment utilizing IE,
anticipated adherence to an IE treatment, credibility and expectancy, and acceptability of an IE
intervention in an online sample of adults with high AS. Given the numerous costs associated
with panic disorder (Klerman et al., 1991; Markowitz et al., 1989; Rollman et al., 2005; Schmidt
& Telch, 1997), the results of this study aimed to contribute to improvements in treatment
efficacy, and ultimately, reduce costs associated with panic disorder and the many other
conditions treated by IE. Extensive research demonstrates AS is a critical component in the
development, maintenance, and treatment of panic disorder (Baillie & Rapee, 2005; McNally,
2002; Reiss, 1991) as well as other anxiety disorders (Taylor et al., 1992), and mood disorders
(Cox et al., 2001; Otto et al., 1995; Simon et al., 2005). Therefore, a clinical analogue sample of
adults with elevated AS was utilized to examine the aims of the current study. In sum, results
revealed no differences between conditions in treatment selection, willingness to begin
treatment, anticipated adherence, expectancy, or acceptability of an IE intervention. However,
findings revealed that the values rationale did enhance treatment credibility.
The current study used an analogue sample of adults; yet, study metrics indicated that the
symptom severity levels reported by participants were comparable to a clinical sample. The
overall sample endorsed levels of AS higher than those typically found in panic disorder samples
(Rifkin et al., 2015; Taylor et al., 2007), as well as other clinical samples, including obsessivecompulsive disorder (Taylor et al., 2007), social anxiety disorder (Rifkin et al., 2015; Taylor et
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al., 2007), generalized anxiety disorder (Rifkin et al., 2015; Taylor et al., 2007), and
posttraumatic stress disorder (Rifkin et al., 2015). Regarding panic attacks, most participants
(69%) endorsed a history of at least one and near half (56.8%) reported experiencing at least one
in the past year. The majority (84.3%) of participants with a history of at least one panic attack
endorsed the panic attack(s) being unexpected or occurring out of the blue. Further, half of
participants (49.3%) reported a lifetime anxiety disorder diagnosis. Thus, we believe results from
the current study can be generalized to other samples with pathological anxiety.
Findings indicated the treatment rationale did not significantly influence the selection of
an IE provider when provided the option between an IE provider, another mental health care
provider, or no provider. Thus, findings did not support the hypothesis that participants who
received a values rationale would be more likely to select an IE provider. There are a few
potential reasons for this finding. First, evidence indicates that gender (Avcı et al., 2019),
credentials, specific expertise, and personal characteristics (e.g., friendly, nonjudgmental;
Lipscomb et al., 2010) are variables of highest importance to individuals when selecting a mental
health provider; however, only limited information regarding expertise was provided in the
current study. It could be that participants prioritized the other aforementioned variables, for
which they had no information, or participants may not have identified high AS as problematic to
their functioning or simply were not interested in treatment for AS. For instance, 17% of
participants selected “no provider,” which may indicate lack of interest in treatment or the
providers based off of the limited information that was provided. Future research should evaluate
variables of importance when selecting potential treatment providers. Additionally, participants
may not have appreciated the unique differences among providers regarding treatment efficacy.
For instance, prior studies have shown that patients place more emphasis on information about a
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provider’s specific performance information (Boswell et al., 2018) and prioritize therapeutic
relationship, therapist qualities, therapist experience, and being allowed to do more of the
speaking in session over intervention empirical support (Swift & Callahan, 2010). Information
was provided about the efficacy of the treatment provided by the provider (i.e., “Interoceptive
exposure provider, which has shown to be effective for most people;” “Other mental health care
provider, even if the treatment may not work”); however, additional information may have
clarified the distinctions among these providers. For instance, information regarding first-line
treatments and evidence-based practice may have advantageous. Nevertheless, it remains
possible that other factors, such as working alliance (Garcia & Weisz, 2002) and other therapist
characteristics (Swift & Callahan, 2010), may be prioritized over provider and treatment
efficacy. Future research should provide information about IE as an evidence-based treatment for
AS, as well as information about other non-evidence-based treatment options that are typically
offered in outpatient treatment settings. Future research should also provide characteristic
information about the providers from whom treatment is being offered.
Overall, approximately one-third (32%) of participants were willing to begin IE
treatment. Prior work has not explicitly evaluated participant willingness to engage in IE;
however, current findings suggest that there were no differences in willingness to begin IE
treatment between the values and standard rationale conditions. Findings may have been
influenced by hesitations related to mental health stigma (Bharadwaj et al., 2017), limited insight
(Mojtabai et al., 2011), and lack of motivation for treatment (Nock & Photos, 2006). Further,
participants may not have believed that the dose of therapy (i.e., one 90-minute session) would
be sufficient or that the treatment would fully address their concerns (Piper et al., 1999).
Unfortunately, the current study did not assess AS-related functional interference or willingness
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to seek treatment for AS-related concerns. Findings may have also been influenced by the
platform of the IE treatment session offered (i.e., telemental health), as internet-delivered CBT
has proven less preferred by potential patients than in-person CBT (Soucy & Hadjistavropoulos,
2017). In addition, factors including limited access to an electronic device with video and audio
capability, a stable and strong enough internet connection to support teleconferencing, or a
private location to engage in telemental health may have posed barriers to participants electing to
book the appointment for treatment (Madigan et al., 2020). Future studies should assess insight
into AS as a problem, perceptions of mental health treatment, motivation for change, perceptions
of internet-delivered treatment, and access to resources needed to engage in telemental health.
The current findings are inconsistent with prior research suggesting that values may
motivate engagement in IE (Maltby & Tolin, 2005; Páez-Blarrina et al., 2008). Specifically,
Páez-Blarrina and colleagues (2008) found that participants who received a values rationale were
more willing to engage in a pain task and tolerate pain via electric shock than those in the control
and no values conditions. Páez-Blarrina and colleagues (2008) utilized a pain task consisting of
electric shocks, assessed willingness to tolerate physical pain, and the rationale was delivered inperson involving interaction and personalization; therefore, the salience of the values and pain
task may have contributed to the findings. Although effort was made in the current study to
engage with the participant through questions proposed in the rationale videos (e.g., “Why do
you think they do not quit?” and “Have you ever been, not exactly in such a situation, but in a
somehow similar one…?”), there was no live interaction. Therefore, participants may not have
come into contact with their own personal values during the intervention or related engagement
in IE treatment with pursuing said values. As a more rigorous test of the current hypotheses,
future studies may benefit from including delivery of personalized in-person and interactive
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treatment rationales. Additionally, future studies should assess exposure-based outcome
variables such as willingness to tolerate physical discomfort commonly elicited by IE (e.g.,
respiratory distress associated with the straw breathing task).
Contrary to hypothesis, there were also no differences in anticipated adherence to an IE
treatment between the values rationale and standard rationale conditions. Participants in both
groups reported lower anticipated adherence to treatment compared to scores for exposure
therapy from clinically anxious samples (Blakey et al., 2019; Milosevic & Radomsky, 2013) and
scores for internet-delivered CBT from a clinically anxious sample (Soucy & Hadjistavropoulos,
2017). Additional components provided in the rationale for internet-delivered CBT that may
have contributed to increased anticipated adherence found by Soucy and Hadjistavropoulos
(2017) include: 12 lessons covered in once-weekly sessions with additional check-ins with a
therapist by phone or email, information provided about each lesson, additional perceived
benefits beyond reduction in anxiety reported by patients, and a list of advantages and
disadvantages of the treatment. Future studies should include the previously mentioned
components as well as examine the influence of a values rationale for internet delivered IE
across multiple sessions and/or internet-delivered PCT. As described previously, it could be
possible that the current sample had limited insight into AS as a problem, were simply not
interested in treatment, did not perceive the dose of therapy (i.e., one 90-minute session) would
be sufficient or that the treatment would fully address their concerns. Consequently, they may
not have anticipated adhering to the requirements of IE. Further, limited information about
providers could have contributed to low anticipated adherence, as provider-patient alliance and
communication largely contribute to mental health treatment adherence (Thompson & McCabe,
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2012). Future studies should assess views of IE to gain a better understanding of potential
reasons for low anticipated adherence.
Credibility and expectancy were expected to be similar in both groups, and while there
were no differences in expectancy, the values rationale was rated as significantly more credible
than the standard rationale. These results imply that a values rationale may contribute to
increases in how believable, convincing, and logical the treatment is compared to the standard
rationale for IE treatment. These findings highlight the importance of linking engagement in
treatment to valued domains to increase treatment credibility. Prior research has highlighted the
importance of assessing and strengthening treatment credibility at the onset and throughout
treatment given the association between treatment credibility and posttreatment outcomes
(Constantino et al., 2018). Further, credibility and expectancy scores in the current study were
equivalent to credibility and expectancy scores prior to IE among a high AS sample found by
Smits and colleagues (2008). These results suggest that descriptions and rationales for IE as brief
as three minutes produce the same credibility and expectancy as lengthier versions, which could
potentially lead to reductions in time spent describing IE and the rationale and swifter delivery of
active ingredients of IE treatment.
Lastly, there were no differences in treatment acceptability between the values and
standard rationale conditions, implying that a values rationale does not enhance IE treatment
acceptability. Regarding facets of treatment acceptability assessed, the current sample’s
treatment acceptability and aversiveness scores were equivalent to standard IE scores obtained
from a high AS sample by Deacon and colleagues (2013); however, the likeability ratings were
higher in the current study than standard IE in Deacon and colleagues (2013) study. These
findings suggest that descriptions and rationales for IE as brief as three minutes produce similar
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acceptability ratings and increased likeability than lengthier versions, which could potentially
lead to swifter delivery of active ingredients of IE treatment.
Data were collected in June of 2020; therefore, it is important to interpret the current
findings in the context of the worldwide COVID-19 pandemic. Given the overlap between
COVID-19 and anxiety sensations (e.g., respiratory distress, gastrointestinal symptoms), it could
be that the COVID-19 pandemic and fear of COVID-19 symptoms impacted AS levels in the
current sample. At the time of data collection, 126,393 COVID-19 deaths had been reported in
the United States according to the Centers for Disease Control and Prevention (CDC; CDC,
2020a). Very few (1.5%) participants in the current sample reported having been infected with
COVID-19, and the majority (67.9%) denied knowing anyone personally who had been infected
with COVID-19. Yet, the sample endorsed heightened levels COVID-19-related fears. The
current sample reported elevated fears of COVID-19 compared to a U.S. college sample (Perz et
al., 2020), the only comparative U.S. sample that could be located by the author at the time of
this study’s conclusion. as well as an outpatient psychiatric sample in Taiwan (Chang et al.,
2020).
Fears of COVID-19 may have impacted participants’ responses on self-report measures
and interest in treatment at the time of the study. The COVID-19 pandemic has led to increased
psychiatric morbidity (CDC, 2020b) and exacerbated psychiatric disturbances (Gruber et al., in
press), including anxiety disorders (Asmundson et al., 2020). The current study utilized an
anxious sample, and in light of the recent findings by Park and colleagues (2020) that distraction
is the most commonly utilized coping strategy for COVID-19-related fears, participants may
have been more inclined to engage in distraction rather than seek therapy. Therefore, it could be
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that participants’ methods of distraction prevented identification of anxiety as a problem or that
participants were generally less willing to seek mental health treatment at the time of the study.
Additionally, although effort was made to adhere to the CDC guidelines limiting social
contact to decrease the risk of COVID-19 transmission by offering treatment via telemental
health, it could be that participants declined the appointment due to this platform. In fact,
approximately 41% of participants declined the appointment and endorsed not being interested in
online treatment as the reason. Evidence supports the effectiveness of telemental health care for a
variety of psychological conditions (Langarizadeh et al., 2017), and patients generally indicate
comparable treatment satisfaction and therapeutic alliance as in-person services (JenkinsGuarnieri et al., 2015). However, public attitudes toward include the belief that services provided
via telemental health are not as effective as in-person services (Grubaugh et al., 2008). Future
studies should examine attitudes toward telemental health and access to necessary resources for
the appointment. Additionally, future studies should offer an appointment for in-person IE
treatment. Despite the potential impact of the COVID-19 pandemic, findings from the current
study provide important findings and recommendations for future research.
A few additional limitations and suggestions for future research should be considered.
First, given the potential impact of COVID-19 on the current findings, future studies should
examine responses to a values rationale apart from the potential influence of a worldwide
pandemic. A second potential limitation involves utilization of an analogue sample of
participants who endorsed fear and beliefs about physiological sensations as dangerous rather
than treatment seeking patients with panic disorder diagnoses. The current sample was a nontreatment seeking sample; therefore, a treatment seeking sample that was willing and ready to
change may have responded differently to the rationales. Future studies should examine
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responses to a values rationale in a sample of treatment seeking sample of individuals diagnosed
with panic disorder. A third potential limitation involves lack of information regarding
experience with the treatment examined in this study. Although current or past mental health or
psychiatric treatment was assessed, experience with CBT and/or IE, specifically, was not
assessed. Future studies should examine knowledge of and experience with both CBT and IE. A
fourth potential limitation involves the dose of the rationale and limited interactive delivery of
the rationale. Though the length of the rationale matched that of previous research investigating
the influence of a values rationale (i.e., Páez-Blarrina et al., 2008), it is unclear whether dose
utilized was appropriate or should have been extended in length. Unlike the rationale provided
by Páez-Blarrina and colleagues (2008), however, the rationale was delivered via a pre-recorded
video which differs greatly from how treatment rationales are delivered in treatment settings.
Future investigations should evaluate optimal duration and involve an interactive dialogue to
ensure the adequate dose of rationale. A fifth potential limitation involves the timeliness of the
IE appointment, as evidence indicates longer wait times for care is strongly associated with
treatment non-attendance (e.g., McCullumsmith et al., 2015). The date of the appointment
offered in the current study was approximately two months following participation in the study.
Although participants were presented with the option to request a different appointment date and
time, it could be that participants were interested in seeking treatment immediately or sooner
than two months and did not think that immediate or sooner appointments would be available if
requested. Future studies should examine shorter wait times for appointments for IE treatment. A
sixth potential limitation involves the use of an online platform for data collection. Steps were
taken to increase the likelihood of engagement with the rationale videos; however, it’s uncertain
if participants attended to the videos to receive the full dose delivered. In the context of
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treatment, it is also likely that treatment perceptions are moderated by additional variables, such
as therapeutic rapport and early therapeutic gains (Milosevic & Radomsky, 2013). Future
investigations should involve in person delivery of rationales and data collection.
In conclusion, prior evidence suggests values may motivate engagement in IE (Bluett,
2014; Branstetter-Rost et al., 2009; Karekla, 2004; Maltby & Tolin, 2005; Páez-Blarrina et al.,
2008; Westra & Dozois, 2006); however, there is no research prior to this study that examines
the impact of a values rationale on motivation to engage in IE. The current study is an important
first step toward identifying strategies that may contribute to engagement in IE, the most
efficacious component of CBT for panic disorder Barlow, 2002; Chambless & Peterman, 2004;
Craske & Barlow, 2000; Craske et al., 1997; Klosko et al., 1990; Penava et al., 1998; Pompoli et
al., 2018, which has the potential to improve treatment efficacy and reduce costs associated with
panic disorder and other conditions associated with high AS. Overall, the findings from the
current study provide insights into the impact of a brief values rationale on factors related to IE
treatment. Relative to those who received the standard rationale for IE, the values rationale
yielded similar effects on selection of an IE provider, willingness to begin IE treatment,
anticipated adherence to IE, treatment expectancy and acceptability. The values rationale did,
however, yield greater treatment credibility compared to the standard rationale. In light of the
current methodological limitations, recommendations for future studies include assessment of the
influence of a values rationale for IE delivered in a face-to-face, interactive manner barring the
context of a viral pandemic with a variety of IE treatment appointment options among a
treatment-seeking panic disorder sample.
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Table 1
Sociodemographic Characteristics of Participants
Values
Characteristic
(n = 72)
n (%)
Gender
Female
42 (58.3)
Male
29 (40.3)
Transgender
1 (1.4)
Non-binary
0 (0)
Race
White
58 (80.6)
Black/African American
4 (5.6)
Asian/Southeast Asian
9 (12.5)
American Indian/Alaska Native
1 (1.4)
Ethnicity
Hispanic or Latino
7 (9.7)
Sexual orientation
Heterosexual/straight
55 (76.4)
Gay
1 (1.4)
Lesbian
2 (2.8)
Bisexual
11 (15.3)
Queer
1 (1.4)
Asexual
2 (2.8)
Relationship status
In a relationship
49 (68.1)
Married or in a civil union
27 (37.5)
Living together
20 (27.8)
Living apart
6 (8.3)
Student status
Not a student
53 (73.6)
Part-time student
4 (5.6)
Full-time student
15 (20.8)
Employment status
Employed full-time
34 (47.2)
Employed part-time
15 (20.8)
Unemployed
15 (20.8)
Retired
1 (1.4)
Other
7 (9.7)
Highest education level
Some high school
2 (2.8)
Graduated high school
10 (13.9)
Some college, no degree
15 (20.8)
Two-year degree or technical
8 (11.1)
67

Standard
(n = 74)
n (%)

Total
(N = 146)
n (%)

37 (50)
34 (45.9)
0 (0)
3 (4.1)

79 (54.1)
63 (43.2)
1 (0.7)
3 (2.1)

49 (66.2)
9 (12.2)
15 (20.3)
1 (1.4)

107 (73.3)
13 (8.9)
24 (16.4)
2 (1.4)

13 (17.6)

20 (13.7)

61 (82.4)
2 (2.7)
0 (0)
8 (10.8)
0 (0)
3 (4.1)

116 (79.5)
3 (2.1)
2 (1.4)
19 (13)
1 (0.7)
5 (3.4)

42 (56.8)
21 (28.4)
16 (21.6)
10 (13.5)

91 (62.3)
48 (32.9)
36 (24.7)
16 (11)

58 (78.4)
4 (5.4)
12 (16.2)

111 (76)
8 (5.5)
27 (18.5)

40 (54.1)
15 (20.3)
19 (25.7)
0 (0)
0 (0)

74 (50.7)
30 (20.5)
34 (23.3)
1 (0.7)
7 (4.8)

0 (0)
5 (6.8)
21 (28.4)
8 (10.8)

2 (1.4)
15 (10.3)
36 (24.7)
16 (11)

Four-year degree
Some graduate school, no degree
Master’s degree
Professional or doctoral degree

28 (38.9)
5 (6.9)
3 (4.2)
1 (1.4)
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31 (41.9)
1 (1.4)
7 (9.5)
1 (1.4)

59 (40.4)
6 (4.1)
10 (6.8)
2 (1.4)

Table 2.
Descriptive Statistics for Self-Report Measures
M (SD)
M (SD)
M (SD)
Total
Values
Standard
(N = 146)
(n = 72)
(n = 74)
ASI-3 Total
37.23 (10.94)
37.61 (10.41)
36.86 (11.49)
ASI-3 Physical
11.66 (5.36)
12.01 (5.57)
11.32 (5.17)
ASI-3 Cognitive
10.30 (5.78)
10.38 (5.60)
10.23 (5.99)
ASI-3 Social
15.27 (4.52)
15.22 (4.81)
15.31 (4.25)
FCV-19S
19.49 (7.01)
20.44 (6.90)
18.55 (7.03)
APPQ Social
37.73 (14.44)
38.93 (15.36)
36.57 (13.48)
APPQ Agoraphobia
24.53 (12.72)
25.71 (12.59)
23.39 (12.82)
APPQ Panic
16.11 (10.93)
16.14 (8.49)
16.08 (12.93)
Willingness
53.39 (23.12)
53.20 (22.09)
53.57 (24.24)
TAAS
33.51 (11.22)
31.94 (11.00)
35.04 (11.30)
CEQ-Credibility
5.72 (2.06)
6.15 (1.77)
5.29 (2.23)
CEQ-Expectancy
5.81 (2.72)
6.19 (2.58)
5.44 (2.81)
TAQ
7.85 (2.92)
8.19 (2.87)
7.51 (2.95)
Note. ASI-3 Total = Anxiety Sensitivity Index – 3 – Total score; ASI-3 Physical = Anxiety
Sensitivity Index – 3 – Physical Concerns subscale; ASI-3 Cognitive = Anxiety Sensitivity Index
– 3 – Cognitive Concerns subscale; ASI-3 Social = Anxiety Sensitivity Index – 3 – Social
Concerns subscale; FCV-19S = Fear of Coronavirus-19 Scale; APPQ Social = Albany Panic and
Phobia Questionnaire – Social subscale; APPQ Agoraphobia = Albany Panic and Phobia
Questionnaire – Agoraphobia subscale; APPQ Panic = Albany Panic and Phobia Questionnaire –
Panic subscale; Willingness = Willingness to tolerate distress; TAAS = Treatment Acceptability
and Adherence Scale; CEQ-Credibility = Credibility/Expectancy Questionnaire – Credibility
subscale; CEQ-Expectancy = Credibility/Expectancy Questionnaire – Expectancy subscale; TAQ
= Treatment Acceptability Questionnaire; Values = values rationale condition; Standard =
standard rationale condition.
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Table 3
Results of Chi-square Test and Descriptive Statistics for Provider Selection by Condition
Provider Selection
Condition
IE Provider
Other Provider No Provider
Values
50 (69.4%)
12 (16.7%)
10 (13.9%)
Standard
41 (55.4%)
18 (24.3%)
15 (20.3%)
2
Note.  = 3.06, df = 2. Numbers in parentheses indicate column percentages.
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Table 4
Results of Chi-square Test and Descriptive Statistics for Appointment Booking by Condition
Appointment Booking
Condition
No, not
No, not
No, but would Yes, I would
interested in
interested in
like another
like to book
treatment
online
appointment
this
treatment
time
appointment
Values
20 (27.8%)
27 (37.5%)
15 (20.8%)
10 (13.9%)
Standard
19 (25.7%)
33 (44.6%)
9 (12.2%)
13 (17.6%)
2
Note.  = 2.49, df = 3. Numbers in parentheses indicate column percentages.
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APPENDIX A: MEASURES
Demographic and Medical Questionnaire
1. Age:

_____

2. Gender:
_____ (1) Female
_____ (2) Male
_____ (3) Transgender
_____ (4) Other___________

3. What sex were you assigned at birth, on your original birth certificate?
____ (1) Male
____ (2) Female

4. Race:
_____ (1) American Indian/Alaska Native
_____ (2) Asian/Southeast Asian
_____ (3) Black/African American
_____ (4) Native Hawaiian/Other Pacific Islander
_____ (5) White

5. Ethnicity: Are you Hispanic or Latino?
_____ (1) Yes
_____ (2) No

6. Are you currently in a romantic relationship with a partner or partners?
_____(1)No
_____(2)Yes, one partner
_____(3)Yes, I have multiple partners
If yes, are you (mark all that apply)
_____(1)Not applicable
_____(2)Married or in a civil union
_____(3)Living together
_____(4)Living apart

7. Are you a student?
_____(1)Not a student
_____(2)Part-time student
_____(3)Full-time student

8. What is your employment status?
_____(1)Unemployed
_____(2)Employed part-time (working 1-30 hours/week)
_____(3)Employed full-time (working more than 30 hours a week)
_____(4)Retired
_____(5)Other, please specify: _____
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9. What’s the highest level of education you have achieved?
____ (1) No high school
____ (2) Some high school
____ (3) Graduated high school
____ (4) Some college, but did not graduate
____ (5) Graduated with 2-year degree or technical school
____ (6) Graduated with 4-year degree
____ (7) Some graduate school but no graduate degree
____ (8) Attained Master’s degree (i.e., M.A., M.S., M.B.A., etc.)
____ (9) Attained Professional or Doctoral degree (i.e., Ph.D., J.D., M.D., etc.)

10. How do you self-identify?
___ (1) Gay
___ (2) Lesbian
___ (3) Bisexual
___ (4) Queer
___ (5) Questioning
___ (6) Heterosexual/Straight
___ (7) Asexual
___ (8) Other (Please specify): __________________

11. Please list your current and past medical conditions:
Dates (from-to)
Medical conditions
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________

12. Have you ever been diagnosed with an anxiety disorder? (yes/no)
If yes, list diagnoses:
Date
Diagnosis
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________

13. Please list all current medications you take:
Medication Name
Dosage
How often
How long have you been taking it?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
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________________________________________________________________________
________________________________________________________________________

a.

b.

Have you had any changes to your medications in the last 3
months?
If yes, please describe:
Have you consistently taken your medications over the last 3
months?
If no, please describe:

Yes

No

Yes

No

14. Please list any psychiatric medications you’ve taken in the past:
Medication Name
Dosage
When did you start?
When did you stop?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________

15. Please list any current or past mental health or psychiatric treatment (therapy):
Dates
Details
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________

16. Have you ever had one or more panic attacks in your life? (yes/no)
a. Sometimes panic attacks are unexpected or occur out of the blue. Have you ever
had a panic attack like this? (yes/no)
b. For approximately how long have you been experiencing panic attacks?
______ years ______ months
c. In the past year, approximately how many panic attacks have you had? ______
d. Of those that you’ve had in the past year, how many were expected or cued (i.e.,
you knew one was coming)? ______
e. How many panic attacks in the past year were unexpected or occurred out of the
blue? ______
17. To what extent has your daily schedule and life been affected by COVID-19?
_____(1)No disruption at all.
_____(2)A little disruption, but I mostly function well.
_____(3)Many things are disrupted, but I can still manage.
_____(4)My life is disrupted in many ways and I have trouble managing.
_____(5)My life is completely disrupted and I cannot function at all.
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18. Do you know someone personally who has been infected with COVID-19?
_____ (1)No
_____ (2)Yes
_____ (3)Don’t know

19. Have you been infected with COVID-19?
_____ (1) No
_____ (2)Yes
_____ (3)Don’t know

20. Do you live in a state that has instituted a stay-at-home order?
_____ (1)No
_____ (2)Yes
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Albany Panic and Phobia Questionnaire (APPQ)
Please rate, on the following scale, the amount of fear that you think you would experience in
each of the situations listed below if they were to occur in the next week. Try to imagine yourself
actually doing each activity and how you would feel.
0 ---------- 1 ---------- 2 ---------- 3 ---------- 4 ---------- 5 ---------- 6 ---------- 7 ---------- 8
No fear
Slight fear
Moderate fear
Marked fear
Extreme fear

_____ 1. Talking to people.

_____ 25. Staying overnight away from home.

_____ 2. Going through a car wash.

_____ 26. Feeling the effects of alcohol.

_____ 3. Playing an active sport on a hot day.

_____ 27. Going over a long, low bridge.

_____ 4. Blowing up a balloon quickly.
_____ 5. Eating in front of others.
_____ 6. Hiking on a hot day.
_____ 7. Getting gas at a dentist.
_____ 8. Interrupting a meeting.
_____ 9. Giving a speech.
_____ 10. Exercising intensely alone.
_____ 11. Going long distances from home alone.
_____ 12. Introducing yourself to groups.
_____ 13. Walking alone in isolated areas.
_____ 14. Driving on highways.
_____ 15. Wearing striking, showy clothes.
_____ 16. Possibility of getting lost.
_____ 17. Drinking a strong cup of coffee.
_____ 18. Sitting in the center of a cinema.
_____ 19. Running up stairs.
_____ 20. Riding on a subway.
_____ 21. Speaking on the telephone.
_____ 22. Meeting strangers.
_____ 23. Writing in front of others.
_____ 24. Entering a room full of people.
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Anxiety Sensitivity Index – 3 (ASI-3)
Please rate each item by selecting one of the five answers for each question. Please answer each
statement by circling the number that best applies to you.

1. It is important not to appear nervous.
2. When I cannot keep my mind on a task, I worry
that I might be going crazy.
3. It scares me when my heart beats rapidly.
4. When my stomach is upset, I worry that I might
be seriously ill.
5. It scares me when I am unable to keep my mind
on a task.
6. When I tremble in the presence of others, I fear
what people might think of me.
7. When my chest feels tight, I get scared that I
won’t be able to breathe properly.
8. When I feel pain in my chest, I worry that I’m
going to have a heart attack.
9. I worry that other people will notice my anxiety.
10. When I feel “spacey” or spaced out I worry that
I may be mentally ill.
11. It scares me when I blush in front of people.
12. When I notice my heart skipping a beat, I worry
that there Is something seriously wrong with me.
13. When I begin to sweat in a social situation, I fear
people will think negatively of me.
14. When my thoughts seem to speed up, I worry
that I might be going crazy.
15. When my throat feels tight, I worry that I could
choke to death.
16. When I have trouble thinking clearly, I worry
that there is something wrong with me.
17. I think it would be horrible for me to faint in
public.
18. When my mind goes blank, I worry there is
something terribly wrong with me.
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Credibility/Expectancy Questionnaire (CEQ)
We would like you to indicate below how much you believe, right now, that the treatment you
will receive will help to reduce your anxiety. Belief usually has two aspects to it: (1) what one
thinks will happen and (2) what one feels will happen. Sometimes these are similar; sometimes
they are different. Please answer the questions below. In the next set, answer in terms of what
you think. In the second set answer in terms of what you really and truly feel.
1. At this point, how logical does the therapy offered to you seem?
1
2
3
not at all logical

4
5
somewhat

6
logical

7

8
9
very logical

2. At this point, how successfully do you think this treatment will be in reducing your anxiety
symptoms?
1
2
3
not at all successful

4
5
6
somewhat successful

7

8
9
very successful

3. How confident would you be in recommending this treatment to a friend who experiences
similar problems?
1
2
3
not at all confident

4
5
6
somewhat confident

7

8
9
very confident

4. By the end of the therapy period, how much improvement in your anxiety symptoms do you
think will occur?
0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Set II
For this set, close your eyes for a few moments, and try to identify what you really feel about the
therapy and its likely success. Then answer the following questions.
1. At this point, how much do you really feel that therapy will help you to reduce your anxiety
symptoms?
1
2
not at all

3

4

5
6
somewhat

7

8

9
very much

2. By the end of the therapy period, how much improvement in your anxiety symptoms do you
really feel will occur?
0%
10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
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Treatment Acceptability Questionnaire
1. At this point, how aversive does the therapy offered to you seem?
0
Not at all aversive

1

2

3

4
Extremely aversive

2. At this point, how acceptable does the therapy offered to you seem?
0
1
Not at all acceptable

2

3

4
Extremely acceptable

3. At this point, how likeable does the therapy offered to you seem?
0
Not at all likeable

1

2
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3

4
Extremely likeable

Fear of COVID-19 Survey (FCV-19S)
Please indicate your level of agreement with the statements below from “strongly disagree” to
“strongly agree.”
1
2
Strongly Disagree
disagree

1. I am most afraid of coronavirus-19.
2. It makes me uncomfortable to think
about coronavirus-19.
3. My hands become clammy when I
think about coronavirus-19.
4. I am afraid of losing my life because
of coronavirus-19.
5. When watching news and stories
about coronavirus-19 on social media, I
become nervous or anxious.
6. I cannot sleep because I’m worrying
about getting coronavirus-19.
7. My heart races or palpitates when I
think about getting coronavirus-19.

1
1

2
2

3
Neither
agree
nor
disagree
3
3

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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4
Agree

5
Strongly
agree

4
4

5
5

Willingness to Begin Treatment Item
1. There is an opening for treatment to be provided free of cost on Monday, august 10 at 9:00
AM CST via telehealth from a therapist at the University of Mississippi Psychological Services
Center. It does not matter where in the United States you are physically located. All that would
be needed is: an hour and a half of your time, an electronic device with video and audio
capability (e.g., laptop, smartphone, tablet), and a stable internet connection. Would you like to
book this appointment for treatment?
a) No, because I am not interested in treatment
b) No, because I am not interested in online treatment
c) No, because this date and time does not work for me, but I am interested in selecting another
appointment time
Select date and time: ____
d) Yes, I would like to book this appointment.

**Note: The following feedback will be given if option c OR d is selected:
“Thank you for electing to book an appointment. This response choice was used as a
hypothetical option and therefore does not reflect a scheduled appointment with a therapist.
Information will be provided at the end of this study for those interested in seeking treatment
services, including links to two directories of therapists for whom you can search by zip code.”
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Treatment Selection Item
1. Select a provider with whom you would like to follow through with treatment.
a) Interoceptive exposure provider, which has been shown to be effective for most individuals
b) Other mental health care provider, even if the treatment may not work
c) No provider; I chose to continue to feel distressed
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APPENDIX B: TREATMENT RATIONALES
Psychoeducation + Values Rationale (Experimental Condition):
I would like to talk to you now about why people fear uncomfortable body sensations, and what
can be done to overcome this fear. There are three primary reasons why people might fear their
own body sensations. First, they may believe that certain sensations have potentially harmful
consequences. For example, some people think that extreme lightheadedness or dizziness can
cause them to pass out. Second, when people repeatedly experience uncomfortable body
sensations and anxiety at the same time, they can gradually develop a conditioned, gut-level fear
response to the sensations. Third, when people go out of their way to avoid uncomfortable body
sensations, they are unable to learn that their sensations are not harmful, that they are tolerable,
and that they will eventually go away.
As you know, many people have a really hard time with anxiety and uncomfortable body
sensations, but they persist and keep working even with very severe discomfort. Have you known
or heard of someone who has been treated with chemotherapy? You know that sometimes this
treatment is very aversive, people refer that they feel dizzy and sick, they lose their hair and feel
a lot of unpleasant symptoms, but even so, only a few refuse the treatment. Why do you think
most of them do not refuse or quit? (Participant will respond something like “Because they need
the treatment to live or recover their health”). Exactly, because feeling bad during a short period
could be related to recovering from cancer in the long run, or at least to an improvement in
quality of life. Have you ever been, not exactly in such a situation, but in a somehow similar one
where you have felt bad for a while in order to achieve something important, something that was
meaningful to you, something you value? (Elicit one or two personal examples that would
correspond with such experiences – If the participant does not provide an example, say, For
example, when you spend time studying, or when you travel a long distance to see a loved one, in
the short run it is painful but you do it because getting a degree, or maintaining those
relationships are important to you. Then ask for an example).
In this study, you will participate in an effective treatment for helping people tolerate
uncomfortable body sensations so you can engage in more things that matter to you, that you
value, like (refer to example provided). To do this, you will engage in an overbreathing exercise
to produce the symptoms associated with anxiety. You will repeat the exercise enough times and
in just the right way so that you learn that the symptoms are not harmful, that you can handle
them, and that you can break the conditioning, so you can engage in more that you value.
The technique you will practice today involves repeatedly performing an overbreathing exercise
for periods of one minute. After each minute-long trial, you will have a resting period during
which you will be asked to rate your anxiety, negative predictions about the body sensations you
are experiencing, and your ability to tolerate your uncomfortable body sensations. You will be
asked to repeatedly practice the overbreathing exercises until you become convinced that your
body sensations are not dangerous, and that are able to tolerate them. This will help you learn
that the symptoms are not harmful, that you can handle them, and help you break the conditioned
association between the sensations and anxiety, so you can engage in more that you value.
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Psychoeducation + Standard Rationale (Control Condition):
I would like to talk to you now about why people fear uncomfortable body sensations, and what
can be done to overcome this fear. There are three primary reasons why people might fear their
own body sensations. First, they may believe that certain sensations have potentially harmful
consequences. For example, some people think that extreme lightheadedness or dizziness can
cause them to pass out. Second, when people repeatedly experience uncomfortable body
sensations and anxiety at the same time, they can gradually develop a conditioned, gut-level fear
response to the sensations. Third, when people go out of their way to avoid uncomfortable body
sensations, they are unable to learn that their sensations are not harmful, that they are tolerable,
and that they will eventually go away.
As you know, many people have a really hard time with anxiety and uncomfortable body
sensations, and even when they want to do things, sometimes they can’t because of the severe
discomfort they suffer. Imagine a person who decides he wants to run 5 miles every day. But as
soon as he hits 1.5 miles his heart is pounding, he breaks into a sweat, and has difficulty
breathing then quits. Why do you think he has to quit? (Participant will respond something like
“Because he couldn’t stand the pain and sometimes you have to quit”). Exactly, he will have to
quit pursuing this goal because he cannot continue with such discomfort. Have you ever been,
not exactly in that situation, but in a somehow similar one where you had to quit doing
something because you were experiencing lots of discomfort? (Elicit one or two personal
examples that would correspond with such experiences – If the participant does not provide an
example, say, For example, when you are studying so hard and you have to stop because of an
unbearable headache. You want to continue, but sometimes you can’t because the pain becomes
a barrier for doing what you want to do. Then ask for an example).
In this study, you will participate in an effective treatment for reducing fears of uncomfortable
body sensations so you can feel better. To do this, you will engage in an overbreathing exercise
to produce the symptoms associated with anxiety. You will repeat the exercise enough times and
in just the right way so that you learn that the symptoms are not harmful, that you can handle
them, and that you can break the conditioning, so you can experience less discomfort related to
body sensations.
The technique you will practice today involves repeatedly performing an overbreathing exercise
for periods of one minute. After each minute-long trial, you will have a resting period during
which you will be asked to rate your anxiety, negative predictions about the body sensations you
are experiencing, and your ability to tolerate your uncomfortable body sensations. You will be
asked to repeatedly practice the overbreathing exercises until you become convinced that your
body sensations are not dangerous, and that are able to tolerate them. This will help you learn
that the symptoms are not harmful, that you can handle them, and help you break the conditioned
association between the sensations and anxiety, so you can experience less discomfort related to
body sensations.
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and body dysmorphic concerns. Journal of Nervous and Mental Disease. Advance online
publication. doi:10.1097/NMD.0000000000001355
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4. Sandoz, E. K., Boullion, G. Q., Mallik, D., & Hebert, E. R. (2020). Relative associations
of body image avoidance constructs with eating disorder pathology in a large college
student sample. Body Image, 34, 242-248. doi:10.1016/j.bodyim.2020.07.002
3. Boullion, G. Q., Pavlacic, J. M., Schulenberg, S. E., Buchanan, E. M., & Steger, M. F.
(2020). Meaning, support, and resilience as predictors of posttraumatic growth: A study
of the Louisiana flooding of August 2016. American Journal of Orthopsychiatry, 90(5),
578-585. doi:10.1037/ort0000464
2. Turner, K. A., Williamson, J. M., & Boullion, G. Q. (2018). Recent research publications
of interest to logotherapists. The International Forum for Logotherapy, 41, 57-62.
1. Williamson, J. M., Turner, K. A., & Boullion, G. Q. (2018). Recent research publications
of interest to logotherapists. The International Forum for Logotherapy, 41, 38-44.
BOOK CHAPTERS
1. Sandoz, E. K., Boullion, G. Q., & Rachal, D. O. (2020). Second and third wave behavior
therapies. In R. A. Rehfeldt, J. Tarbox, M. Fryling, and L. Hayes (Eds.), Applied
behavior analysis of language and cognition. Oakland, CA: New Harbinger.
MANUSCRIPTS UNDER REVIEW
2. Boullion, G. Q., & Sandoz, E. K. (under review). Experiential avoidance moderates the
relationship between anxiety and valued behavior in daily experiences. Manuscript
submitted for publication.
1. Sandoz, E. K., Bordieri, M. J., Boullion, G. Q., & Tyndall, I. (under review). An
examination of transformation of evaluative and consequential functions through derived
relations with participant-generated values-relevant stimuli. Manuscript submitted for
publication.
PROFESSIONAL RESEARCH PRESENTATIONS, POSTERS, & PANELS____________
60. Dixon, L. D., Schadegg, M. J., Boullion, G. Q., Witcraft, S. M., & Perry, M. P. (2019,
November). Obsessive-compulsive related disorders, emotion regulation, and quality of
life in adults with skin disease. Paper presented at the 53rd Annual Association for
Behavioral and Cognitive Therapy Convention, Atlanta, GA.
59. Boullion, G. Q., Perry, M. P., Witcraft, S. M., Schadegg, M. J., & Dixon, L. J. (2019,
November). Social anxiety and loneliness: The indirect effect of emotion regulation
difficulties. Poster presented at the 53rd Annual Association for Behavioral and Cognitive
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Therapy Convention, Atlanta, GA.
58. Perry, M.M, Boullion, G. Q., Schadegg, M.J., Witcraft, S.M. & Dixon, L. J. (2019,
November). Examining interpersonal and intrapersonal emotion regulation, social
anxiety, and aggression among college students. Poster presented at the 53rd Annual
Association for Behavioral and Cognitive Therapy Convention, Atlanta, GA.
57. Schadegg, M. J., Witcraft, S. M., Perry, M. M., Boullion, G. Q., & Dixon, L. J. (2019,
November). An aggressive reaction to sound: The interactive effects of anxiety sensitivity
and misophonia on facets of aggression. Poster presented at the 53rd Annual Association
for Behavioral and Cognitive Therapy Convention, Atlanta, GA.
56. Witcraft, S. M., Schadegg, M. J., Boullion, G. Q., Perry, M. M., & Dixon, L. J. (2019,
November). What sensitivities matter in dental anxiety? Investigating sensitivity
to anxiety, pain, and disgust. Poster presented at the 53rd Annual Association for
Behavioral and Cognitive Therapy Convention, Atlanta, GA
55. Schmitz, C. R., Berry, S. K., Boullion, G. Q., & Dixon, L. D. (2019, April). An
examination of gender differences and distress tolerance in relation to smoking status.
Poster presented at the 6th Annual University of Mississippi Conference on Psychological
Science, Oxford, MS.
54. Berry, S. K., Boullion, G. Q., & Dixon, L. D. (2019, April). Perceived stress and skin
symptoms in a college sample. Poster presented at the 6th Annual University of
Mississippi Conference on Psychological Science, Oxford, MS.
53. Boullion, G. Q., & Dixon, L. J. (2019, March). How does mental health affect loneliness
in college students? Paper presented at the 9th Annual Graduate Research Symposium,
University of Mississippi, Oxford, MS.
52. Boullion, G. Q., Dixon, L. J., Perry, M. P., & Witcraft, S. M. (2018, November).
Emotion regulation difficulties and depression among individuals with dermatological
and body dysmorphic concerns. Paper presented at the Association for Behavioral and
Cognitive Therapies 52nd Annual Convention, Washington, DC.
51. Perry, M. M., Boullion, G. Q., Witcraft, S. M., Viana, A., & Dixon, L. J. (2018,
November). The importance of a mother's perceived ability to regulate emotions in
postpartum maternal quality of life and parenting distress. Poster presented at the
Association for Behavioral and Cognitive Therapies 52nd Annual Convention,
Washington, DC.
50. Witcraft, S. M., Perry, M. M., Boullion, G. Q., & Dixon, L. J. (2018, November). The
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moderating role of anxiety sensitivity social concerns in stress and quality of life among
adults with skin disease. Poster presented at the Association for Behavioral and Cognitive
Therapies 52nd Annual Convention, Washington, DC.
49. Thorn, M., Boullion, G. Q., Hebert, E. R., Kellum, K. K., & Wilson, K. G. (2018, July).
An examination between family stress and psychological flexibility. Poster presented at
the Association for Contextual Behavioral Science 16th Annual World Conference,
Montreal, QC, Canada.
48. Boullion, G. Q., & Dixon, L. D. (2018, April). Limited access to emotion regulation
strategies influences depression among individuals with dermatological and body
dysmorphic concerns. Paper presented at the 5th Annual University of Mississippi
Conference on Psychological Science, Oxford, MS.
47. Berry, S., Pierce, R., Stockton, T., Boullion, G. Q., & Dixon, L. J. (2018, April). Anxiety,
anxiety sensitivity, and the functional impact of skin picking among individuals with
dermatological concerns. Poster presented at the 5th Annual University of Mississippi
Conference on Psychological Science, Oxford, MS.
46. Pavlacic, J. M., Schulenberg, S. E., Buchanan, E. M., & Boullion, G. Q. (2018, April).
Predicting mindfulness behaviors from values progression using ecological momentary
assessment. Paper presented at the 5th Annual University of Mississippi Conference on
Psychological Science, Oxford, MS.
45. Thorn, M. L., Boullion, G. Q., Hebert, E. R., Kellum, K. K., & Wilson, K. G. (2018,
April). Family stress and psychological flexibility. Poster presented at the 5th Annual
University of Mississippi Conference on Psychological Science, Oxford, MS.
44. Davis, L., Boullion, G. Q., Jacobson, E., Kellum, K. K., & Wilson, K. G. (2018, April).
Disney princess’ influence on dating. Poster presented at the 5th Annual University of
Mississippi Conference on Psychological Science, Oxford, MS.
43. Boullion, G. Q. (2017, September). Moment by moment: Improving self-report methods
with experience sampling. Paper presented at the Mississippi Psychological Association’s
68th Annual Convention, Biloxi, MS.
42. Boullion, G. Q., Turner, K., Williamson, J., Schulenberg, S. E., & Steger, M. F. (2017,
July). Resilience, meaning, and growth among survivors of the August 2016 Louisiana
flooding. Poster presented at the International Positive Psychology Association 5th
Annual World Congress, Montreal, QC, Canada.
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41. Boullion, G. Q. (2017, May). Panel Chair. Behavior analysts’ role in higher education
and university settings. Panel discussion conducted at the Association for Behavior
Analysis International 43rd Annual Convention, Denver, CO.
40. Summers, V., Williams, N., Boullion, G. Q., & Sandoz, E. K. (2017, May). Moving with
meaning: Examining the impact of stimuli with derived values functions on behavioral
flexibility. Paper presented at the Association for Behavior Analysis International 43rd
Annual Convention, Denver, CO.
39. McManus, J. D., Bordieri, M., Boullion, G. Q., Butcher, G., & Sandoz, E. K. (2017,
May). Assessing changes in body image flexibility following flexibility-based
interventions. Paper presented at the Association for Behavior Analysis International 43rd
Annual Convention, Denver, CO.
38. Boullion, G. Q., Williams, N., & Sandoz, E. K. (2016, June). Values and behavioral
flexibility: What are the effects of valuing on sensitivity to contingencies of
reinforcement? Paper presented at the Association for Contextual Behavioral Science 14th
Annual World Conference, Seattle, WA.
37. Sandoz, E. K., Auzenne, J., Butcher, G., & Boullion, G. Q. (2016, June). The body image
flexibility assessment procedure: Development of a behavioral measure of body image
flexibility. Paper presented at the Association for Contextual Behavioral Science 14th
Annual World Conference, Seattle, WA.
36. Boullion, G. Q., Williams, N., & Sandoz, E. K. (2016, May). Values and behavioral
flexibility: What are the effects of valuing on sensitivity to contingencies of
reinforcement. Paper presented at the Association for Behavior Analysis International
42nd Annual Conference, Chicago, IL.
35. Auzenne, J., Williams, N., Butcher, G., Boullion, G. Q., Chiasson, H., Bordieri, M., &
Sandoz, E., K. (2016, May). Creating a measure that measures up: Exploring Self-report,
Experience Sampling, and Behavioral Measures of Body Image Flexibility. Paper
presented at the Association for Behavior Analysis International 42nd Annual Conference,
Chicago, IL.
34. Protti, T., Williams, N., Boullion, G. Q., Hebert, E., Sandoz, E. K., & Bordieri, M.
(2016, May). Learning with purpose: A preliminary demonstration of derived
transformation of values functions. Paper presented at the Association for Behavior
Analysis International 42nd Annual Conference, Chicago, IL.
33. Cantu, G., Williams, N., Auzenne, J., Butcher, G., Boullion, G. Q., Bordieri, M., &
Sandoz, E. K. (2016, May). Assessing body-relevant behavior: Examining convergence
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between two behavioral measures of body image flexibility. Paper presented at the
Association for Behavior Analysis International 42nd Annual Conference, Chicago, IL.
32. Giesemann, A., Boullion, G. Q., & Sandoz, E. K. (2015, May). What matters in the
moment: Relationships among anxiety, experiential avoidance, and valuing in daily
experiences. Paper presented at the Association for Behavior Analysis International 41st
Annual Conference, San Antonio, TX.
31. Williams, N., Boullion, G., Auzenne, J., Hebert, E., Greene, S., Bordieri, M., & Sandoz,
E. (2015, May). Modeling body image flexibility using the concepts of transfer of function
and competing sources of control. Paper presented at the Association for Behavior
Analysis International 41st Annual Conference, San Antonio, TX.
30. Boullion, G. Q., & Sandoz, E. K. (2015, March). Making progress through the obstacles:
Predicting valuing from momentary experiences of anxiety and experiential avoidance.
Paper presented at the Southeastern Chapter Association for Contextual Behavioral
Science 1st Biannual Conference, Lafayette, LA.
29. Williams, N., Boullion, G. Q., Auzenne, J., Hebert, E., Bordieri, M., & Sandoz, E. K.
(2015, March). Modeling body image flexibility using the concepts of transfer of function
and competing sources of control. Paper presented at the Southeastern Chapter
Association for Contextual Behavioral Science 1st Biannual Conference, Lafayette, LA.
28. Burns, L. C., Boullion, G. Q., Auzenne, J., Hebert, E., Greene, S., Bordieri, M., &
Sandoz, E. K. (2014, November). Seeing is believing: Toward a behavioral measure of
psychological flexibility. Paper presented at the Gulf Coast ABA Conference in Baton
Rouge, LA.
27. Burns, L. C., Boullion, G. Q., Auzenne, J., Hebert, E., Greene, S., Bordieri, M., &
Sandoz, E. K. (2014, November). Seeing is believing: Toward a behavioral measure of
psychological flexibility. Paper presented at the Undergraduate Invitational Honors
Conference in Lafayette, LA.
26. Rachal, O., Boullion, G. Q., Jeanis, M., & Sandoz, E. K. (2014, June). Find Mickey: The
impact of community tragedy on valued and avoidant behaviors. Paper presented at the
Association for Contextual Behavioral Science 12th Annual World Conference,
Minneapolis, MN.
25. Auzenne, J., Boullion, G. Q., Hebert, E., Greene, S., Bordieri, M., & Sandoz, E. K.
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(2014, June). Seeing is believing: Toward a behavioral measure of psychological
flexibility. Paper presented at the Association for Contextual Behavioral Science 12th
Annual World Conference, Minneapolis, MN.
24. Boullion, G. Q. (2014, June). Panel Chair. Anxiety and valuing: Using contextual
behavioral science to understand, assess, and increase valued living in individuals with
anxiety. Panel discussion facilitated at the Association for Contextual Behavioral Science
12th Annual World Conference, Minneapolis, MN.

23. LeBleu, E., Boullion, G. Q., Auzene, J., Hebert, E., Greene, S., Bordieri, M., & Sandoz,
E. K. (2014, May). Seeing is believing: Towards a behavioral measure of psychological
flexibility. Paper presented at the Association for Behavior Analysis International 40th
Annual Convention, Chicago, IL.
22. Albarado, R., Boullion, G. Q., Mullen, A., & Sandoz, E. K. (2014, May). Flexibility in
context: Exploring the use of ecological momentary assessment of psychological
flexibility. Paper presented at the Association for Behavioral Analysis International 40th
Annual Convention, Chicago, IL.
21. Thibeaux, K., Mullen, A., Lebleu, E., Greene, S., Hebert, E., Quebedeaux, G., &
Sandoz, E.K. (2013, October). The mind in the mirror: Derived relational responding
and body image. Paper presented at the Louisiana Behavior Analysis Association
Conference, Baton Rouge, LA.
20. Squyres, E., LeBleu, E. L., Quebedeaux, G., Hebert, E., Greene, L., & Sandoz, E. K.
(2013, October). Seeing meaning: Transformation of values functions. Paper presented at
the Louisiana Behavior Analysis Association conference, Baton Rouge, LA.
19. Mullen, A., Quebedeaux, G., Greene, S., Hebert, E., & Sandoz, E. K. (2013, May).
Assessing psychological flexibility: A RFT-based behavioral measure. Paper presented at
the Association for Behavioral Analysis International 39th Annual Convention,
Minneapolis, MN.
18. Thibeaux, K., Greene, S., Hebert, E., Quebedeaux, G., & Sandoz, E. K. (2013, May).
The mind in the mirror: Derived relational responding and body image. Paper presented
at the Association for Behavioral Analysis International 39th Annual Convention,
Minneapolis, MN.
17. LeBleu, E. L., Quebedeaux, G., Hebert, E., Greene, L., & Sandoz, E. K. (2013, May).
Seeing meaning: Transformation of values functions. Paper presented at the Association
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for Behavioral Analysis International 39th Annual Convention, Minneapolis, MN.
16. Eastin, S., Quebedeaux, G., & Sandoz, E. K. (2013, May). Beneath the mask: An
evaluation of cosmetic use among college females. Paper presented at the Association for
Behavioral Analysis International 39th Annual Convention, Minneapolis, MN.
15. Auzenne, J., Quebedeaux, G., Hebert, E., Greene, S., & Sandoz, E.K. (2013, April).
Transformation of values functions through derived relational responding. Paper
presented at the Undergraduate Academic Summit, Monroe, LA.
14. LeBleu, E. L., Greene, S., Quebedeaux, G., Hebert, E., & Sandoz, E. K. (2013, April).
Body image flexibility: Developments with derived relational responding. Paper
presented at the Undergraduate Academic Summit, Monroe, LA.
13. LeBleu, E., Quebedeaux, G., Hebert, E., Greene, S., Bordieri, M., Sandoz, E. K. (2013,
April). Values: Impacts on relational responding. Paper presented at the North Louisiana
Behavioral & Social Sciences Conference; Ruston, LA.

12. Mullen, A., Quebedeaux, G., Hebert, E., Greene, S., Bordieri, M., Sandoz, E. K. (2013,
April). Learning to hate the body: An examination of derived relational responding in the
context of body image disturbance and flexibility. Paper presented at the North Louisiana
Behavioral & Social Sciences Conference; Ruston, LA.

11. Squyres, E., Quebedeaux, G., Greene, S., Cordova, S., & Sandoz, E.K. (2013,
April). DO NOT DISTURB: Body image flexibility and body image disturbance. Paper
presented at the Northern Louisiana Behavioral & Social Sciences Conference, Ruston,
LA.
10. Quebedeaux, G., Eastin, S., Greene, S., Skatulski, L., Sandoz, E. K. (2013, April).
Beneath the mask: An evaluation of cosmetic use among college females. Paper presented
at the Northern Louisiana Behavioral & Social Sciences Conference, Ruston, LA.
9. Squyres, E., Quebedeaux, G., Greene, S., & Sandoz, E. K. (2012, July). DO NOT
DISTURB: Body image flexibility and body image disturbance. Paper presented at the
Association for Contextual Behavioral Science 10th Annual World Conference,
Washington, DC.
8. Mullen, A., Hebert, E., Quebedeaux, G., & Sandoz, E. K. (2012, July). Going from null
to neat-o: Psychological flexibility processes applied to a behavioral statistics study
group. Paper presented at the Association for Contextual Behavioral Science 10th Annual
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World Conference, Washington, DC.
7. Benoit, B., Hebert, E. R., Quebedeaux, G., Greene, S., & Sandoz, E. K. (2012, July).
ACT on campus: Facilitating psychological flexibility for college adjustment. Paper
presented at the Association for Contextual Behavioral Science 10th Annual World
Conference, Washington, DC.
6. Quebedeaux, G., & Sandoz, E. K. (2012, July). Time of the season: Valued living in
college students over the course of a semester. Paper presented at the Association for
Contextual Behavioral Science 10th Annual World Conference, Washington, DC.
5. Quebedeaux, G., & Sandoz, E. K. (2012, July). Beneath the mask: An evaluation of
cosmetic use among college females. Paper presented at the Association for Contextual
Behavioral Science 10th Annual World Conference, Washington, DC.
4. LeBlanc, S., Greene, S., Quebedeaux, G., & Sandoz, E. K. (2012, July). Living beyond
what we see in the mirror: Acceptance and Commitment Therapy for body image. Paper
presented at the Association for Contextual Behavioral Science 10th Annual World
Conference, Washington, DC.
3. Quebedeaux, G. (2012, July). Symposium Chair. More than skin deep: Understanding,
evaluating, and intervening on body image flexibility. Symposium conducted at the
Association for Contextual Behavioral Science 10th Annual World Conference,
Washington, DC.
2. Greene, S., Quebedeaux, G., Leblanc, S., & Sandoz, E. K. (2012, May). Living beyond
what we see in the mirror: Acceptance and Commitment Therapy for body image. Paper
presented at the Association for Behavior Analysis International 38th Annual Convention,
Seattle, WA.
1. Quebedeaux, G., Greene, S., Cordova, S., & Sandoz, E. K. (2012, May). DO NOT
DISTURB: Body image flexibility and body image disturbance. Paper presented at the
Association for Behavior Analysis International 38th Annual Convention, Seattle, WA.
INVITED LECTURES__________________________________________________________
5. Boullion, G. Q., & Dixon, L. J. (2020, February). An introduction to exposure therapy
for anxiety disorders. Workshop presented to research assistants in the Health & Anxiety
Research & Treatment Lab, Oxford, MS.
4. Boullion, G. Q., & Tinsley, D. (2019, October). Effectively communicating and caring
for individuals with dementia. Workshop presented to direct care workers in the
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Enrichment Assisted Living Home at The Baddour Center, Senatobia, MS.
3. Weber, M. C., Liberto, A. K., Polk. A. N., Boullion, G. Q., & Pineau, D. J. (2019,
September). Administration and scoring of the Woodcock Johnson – Fourth Edition (WJIV) Tests of Achievement, Cognitive Abilities, and Oral Language. Workshop presented
to graduate students in the Clinical Psychology Ph.D. Program at the University of
Mississippi, Oxford, MS.
2. Boullion, G. Q. (2017, August). Administration and scoring of the Weschler Adult
Intelligence Scale – Fourth Edition (WAIS-IV). Workshop presented to first year graduate
students enrolled in Techniques of Assessment I: Cognitive Tests course in the Clinical
Psychology Ph.D. Program at the University of Mississippi, Oxford, MS.
1. Quebedeaux, G., Kennison, A., Hebert, J., & Sandoz, E. K. (2011, July). ACT on
campus: Facilitating psychological flexibility for college adjustment. Workshop
presented at the Association for Contextual Behavioral Science 9th Annual World
Conference, Parma, Italy.
GRANT EXPERIENCE_________________________________________________________
Aug 2012 - July 2014

Research Coordinator
Subprogram Grant #: LEQSF(2011-14)-RD-A-29
Project Title: The ‘me’ I see: Verbal learning processes in
body image disturbance
Primary Investigator: Emily K. Sandoz, Ph.D.

RESEARCH EXPERIENCE_________________________ ___________________________
Jan 2018 – Present

Graduate Research Assistant
Health and Anxiety Research and Treatment Lab
University of Mississippi; Oxford, MS
Supervisor: Laura Dixon, Ph.D.

Sept 2016 – May 2018

Graduate Research Assistant
Mississippi Contextual Psychology Lab
University of Mississippi; Oxford, MS
Supervisors: Kelly G. Wilson, Ph.D. & Karen Kate Kellum, Ph.D.

Aug 2016 – Dec 2017

Graduate Research Assistant
Clinical-Disaster Research Center
University of Mississippi; Oxford, MS
Supervisor: Stefan E. Schulenberg, Ph.D.

May 2012 – May 2016

Lab Coordinator & Graduate Research Assistant
Louisiana Contextual Science Research Group
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University of Louisiana at Lafayette; Lafayette, LA
Supervisor: Emily K. Sandoz, Ph.D.
Jan 2011 – May 2012

Undergraduate Research Assistant
Louisiana Contextual Science Research Group
University of Louisiana at Lafayette; Lafayette, LA
Supervisor: Emily K. Sandoz, Ph.D.

EDITORIAL ACTIVITIES ____________________________________________________
Mentored Ad-Hoc Reviewer
Assessment
Journal of Applied Behavior Analysis
Journal of Anxiety Disorders
Journal of Contextual Behavioral Science
Psychological Trauma
The Psychological Record
TEACHING EXPERIENCE_____________________________________________________
July 2017 – May 2018

Behavioral Science Statistics Consultant and Tutor
Department of Psychology
University of Mississippi; Oxford, MS
Supervisor: Rebekah Smith, Ph.D.

Aug 2017 – May 2018

Teaching Assistant
University of Mississippi; Oxford, MS
Course: Statistics for Behavioral Sciences
Instructor: Nicolaas Prins, Ph.D.

Jan 2017 – May 2017

Teaching Assistant
University of Mississippi; Oxford, MS
Course: Introduction to Psychology
Instructors: Tonya Vandenbrink, M.S. &
Joshua Hamer, M.S.

Aug 2015 – May 2016

Adjunct Instructor of Psychology
South Louisiana Community College; Lafayette, LA
Course: Introduction to Psychology I
Department Head: Delana Prudhomme, M.S.

Jan 2014 – May 2014

Teaching Assistant
University of Louisiana at Lafayette; Lafayette, LA
Course: Psychological Counseling
Instructor: Emily K. Sandoz, Ph.D.
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Jan 2012 – Dec 2012

Teaching Assistant
University of Louisiana at Lafayette; Lafayette, LA
Course: Psychology of Adjustment
Instructor: Emily K. Sandoz, Ph.D.

OTHER PROFESSIONAL ACTIVITIES & SERVICE______________________________
August 2018 – April 2020
Mentor

Undergraduate Honors Thesis Graduate Student
University of Mississippi; Oxford, MS
Honors Student: Sarah K. Berry
Thesis: An assessment of acne, stress, and psychological
symptoms in college students: A daily diary study
Chair: Laura J. Dixon, Ph.D.

Jan 2019 – July 2019

Director, Louisiana/Mississippi ACBS 2019 Conference
Organization and Management Team
Association for Contextual Behavioral Science Affiliate
Oxford, MS

Aug 2018 – May 2019

Senator, Graduate Student Council
University of Mississippi; Oxford, MS

Oct 2017 – Aug 2018

Member, Psychology Department Communications
Committee
University of Mississippi; Oxford, MS

Jan 2014 – May 2015

Director, Resource Development for Undergraduates in
Psychology
University of Louisiana at Lafayette; Lafayette, LA

Jan 2013 – May 2015

Graduate Representative, Psychology Colloquium
University of Louisiana at Lafayette; Lafayette, LA

Jan 2013 – May 2015

Director, “Graduate Students Tell All” Series
University of Louisiana at Lafayette; Lafayette, LA

Aug 2010 – May 2011

Executive Board Member, V-Day: A Global Movement
to End Violence Against Women and Girls
Lafayette Chapter; Lafayette, LA

AWARDS AND HONORS ______________________________________________________
2019
2019

Psychology Department Travel Award, University of Mississippi
Outstanding Data Blitz Presentation Award, 9th Annual Graduate Research
Symposium, University of Mississippi
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2019
2018
2018
2016 – 2020
2016
2015
2015
2014
2013
2012
2012 – 2014
2011

Graduate Student Council Travel Award, University of Mississippi
Psychology Department Travel Award, University of Mississippi
Outstanding Research Presentation Award, 5th Annual Conference on
Psychological Science, University of Mississippi
Graduate Assistantship, University of Mississippi
Psychology Department Travel Award, University of Mississippi
Nominated for UL Lafayette Alumni Association’s Outstanding Graduate
Award, University of Louisiana at Lafayette
Nominated for Phi Beta Kappa Association of Southwest Louisiana’s
Richard G. Neiheisel Graduate Award, University of Louisiana at Lafayette
Graduate Student Organization Travel Award, University of Louisiana at
Lafayette
Graduate Student Organization Travel Award, University of Louisiana at
Lafayette
Graduate Student Organization Research Materials Award, University of
Louisiana at Lafayette
Graduate Research Assistantship, University of Louisiana at Lafayette
Student Government Association Undergraduate Travel Award,
University of Louisiana at Lafayette

AFFILIATIONS_______________________________________________________________
Association for Behavioral and Cognitive Therapies
Association for Contextual Behavioral Science
REFERENCES ________________________________________________________________
Available upon request.
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